.
home.aspx
   

Webinars

How pharma marketing can stay ahead of the evolving customer journey
HOW PHARMA MARKETING CAN STAY AHEAD OF THE EVOLVING CUSTOMER JOURNEY
New developments in data and digital are changing traditional customer journeys and forcing pharmaceutical companies to evolve in order to keep up.

Ensuring Compliance for Pharma Companies Through Local Label Deviations
ENSURING COMPLIANCE FOR PHARMA COMPANIES THROUGH LOCAL LABEL DEVIATIONS
Many global pharmaceutical companies are often faced with a volume of content in the field that has grown to a point where the quality of that labeling is unknown. Assessment of what exists and correcting the process to avoid pitfalls in the future can be a daunting task.

Discover the Megatrends Remapping the Pharmaceutical Market
DISCOVER THE MEGATRENDS REMAPPING THE PHARMACEUTICAL MARKET
New Manatt Health Webinar Reveals the Megatrends Reinventing the Ways Your Patient, Provider and Payer Customers Think—and How You Should Respond to Succeed.

Membrane-Based Water for Injection
MEMBRANE-BASED WATER FOR INJECTION
Historically, distillation has been the most common technology used to produce Water for Injection (WFI), due to prior process advantages and historical regulatory requirements.  Changes in the European Pharmacopeiano longer require the use of distillation systems to produce WFI. In this webcas...

Use of Cannabis in Medicine - Drug or Drug?
USE OF CANNABIS IN MEDICINE - DRUG OR DRUG?
In the webinar, Prof. Kirsten Müller-Vahl gives an overview of the use of cannabis in medicine, explains the basics of the endocannabinoid system and introduces the various cannabis compounds - from different cannabis flowers to cannabis-based drugs based on extracts and synthetic cannabinoids....

What pharmaceutical marketers can do now to stay ahead of the evolving customer journey
WHAT PHARMACEUTICAL MARKETERS CAN DO NOW TO STAY AHEAD OF THE EVOLVING CUSTOMER JOURNEY
In association with pharmaphorum, Tag discusses what pharmaceutical marketers can to do stay ahead of the evolving customer journey.

Human relevant model enables better translation to pharmacology and the clinic
HUMAN RELEVANT MODEL ENABLES BETTER TRANSLATION TO PHARMACOLOGY AND THE CLINIC
Current drug development strategies are very expensive and lead to high drug attrition rates. One major reason for low success rates is the lack of predictive preclinical models for efficacy testing. The availability of induced pluripotent stem cell (hiPSC) technologies holds great promise to bring ...

New Tools to Advance CNS Drug Delivery
NEW TOOLS TO ADVANCE CNS DRUG DELIVERY
This webinar will focus on the advantages of nasal powder formulations and on a non-human primate (NHP) model to quantify nose-to-brain delivery of a model compound, sumatriptan. The webinar will also compare pharmacokinetic advantages of nasal powders versus aqueous formulations, as well as in vitr...

Medical Devices in Russia
MEDICAL DEVICES IN RUSSIA
This webinar provides an overview of regulations for medical devices in the Russian Federation. It focuses on submission requirements and processes, lifecycle management and explains the main differences between EU and Russian regulations.

Navigating data management challenges in the pharmaceutical life cycle
NAVIGATING DATA MANAGEMENT CHALLENGES IN THE PHARMACEUTICAL LIFE CYCLE
In this webinar, we introduce you to laboratory information management systems (LIMS) and demonstrate how this software can help you achieve regulatory compliance, quality data management throughout your product’s life cycle.

The Importance of Early Patient Involvement in Clinical Trial Design
THE IMPORTANCE OF EARLY PATIENT INVOLVEMENT IN CLINICAL TRIAL DESIGN
Patient-centricity gets a lot of buzz, but what are the benefits of involving patients in the planning of a clinical trial?

VR & AR for Healthcare & Pharma – Overcome Challenges, Find Opportunities and Drive ROI
VR & AR FOR HEALTHCARE & PHARMA – OVERCOME CHALLENGES, FIND OPPORTUNITIES AND DRIVE ROI
The boom of virtual and augmented reality in the healthcare and pharmaceutical industries is a major growth area for XR. However, there are still many regulatory challenges to overcome, and there are plenty of questions still to be answered.

Patient-Preferred Trials
PATIENT-PREFERRED TRIALS
Clinical trial participants are no longer just numbers on a spreadsheet. They are customers, consumers, patients and people, with all their wonderful complexities, preferences and nuances. And they have a right to choose whether your trial is going to suit them.

Accelerate your Drug Development process with Lonza Engine™
ACCELERATE YOUR DRUG DEVELOPMENT PROCESS WITH LONZA ENGINE™
Speed and quality are key in pharmaceutical manufacturing. How can your equipment add value to your production process? Join the Lonza team to discover how the new Lonza Engine™ equipment portfolio is designed to support bioavailability enhancement, encapsulation and early-phase clinical devel...

Science or Hype? Navigating the Questions about Titanium Dioxide Safety
SCIENCE OR HYPE? NAVIGATING THE QUESTIONS ABOUT TITANIUM DIOXIDE SAFETY
In this webcast, experts will discuss the current status and assess the potential market impact for the pharmaceutical industry. The discussion will review the current legal situation and the position of the different regulatory bodies. Participants will learn about the science-based facts influenci...

What the food supply chain can learn from the pharma industry.
WHAT THE FOOD SUPPLY CHAIN CAN LEARN FROM THE PHARMA INDUSTRY.
With the increase and complexity of the global supply chain, both the pharmaceutical cold chain and temperature-controlled shipping for the food and beverage industry have seen substantial growth over the last few years. It is no coincidence that the food industry is now beginning to look to the pha...

Pharma Product Aggregation: Delivering Business Benefits Beyond Serialization
PHARMA PRODUCT AGGREGATION: DELIVERING BUSINESS BENEFITS BEYOND SERIALIZATION
The cost of returned medicines is estimated to be between $5-10 billion per year in the US alone. However, pharmaceutical companies are struggling to streamline the data flow and verification of returned saleable goods.

Translational Pharmaceutics and the Benefits of Real-Time Adaptive Manufacturing
TRANSLATIONAL PHARMACEUTICS AND THE BENEFITS OF REAL-TIME ADAPTIVE MANUFACTURING
Many pharma companies are seeking new ways of making drug development more efficient and cost-effective through innovation, new technologies and process evolution. This has led to an increase in the outsourcing of development activities to contract research partners who focus solely on disciplines s...

Pharmaceutical Spray Drying to Overcome Poor Drug Solubility
PHARMACEUTICAL SPRAY DRYING TO OVERCOME POOR DRUG SOLUBILITY
This webinar will focus on the benefits of spray-drying in addressing the solubility challenge, detailing how simple, scaleable systems can be quickly developed to provide drug products for clinical evaluation. Approaches for transitioning spray-dried dispersions to formulated solid oral dosage form...

Increasing Efficiency in the Pharma Analytical Workflow through Standards and Reference Materials
INCREASING EFFICIENCY IN THE PHARMA ANALYTICAL WORKFLOW THROUGH STANDARDS AND REFERENCE MATERIALS
The mechanism of headspace SPME will be explained in detail.  Methods for enhancing extraction efficiency will be described. Advantages of headspace SPME over other common extraction methods will be highlighted.

Drug Testing in Hair — Applications and the Experience in Brazil
DRUG TESTING IN HAIR — APPLICATIONS AND THE EXPERIENCE IN BRAZIL
This webinar will discuss the technology of hair testing and present on the situation in Brazil. There is consequently, a very large numbers of hair tests taking place, and laboratories must meet the need for high throughput and sensitivity.

MAT: a powerful tool to assess pyrogenic risk in pharmaceutical process
MAT: A POWERFUL TOOL TO ASSESS PYROGENIC RISK IN PHARMACEUTICAL PROCESS
Microbial risk in pharmaceutical process is not limited to living microorganisms and intact microbial cells. Subcellular components from microorganisms remaining from the production process can be source of pyrogens, compromising product quality and patient safety as these substances are not elimina...

Efficient Handling of Chemical Raw Materials in Biopharmaceutical Manufacturing
EFFICIENT HANDLING OF CHEMICAL RAW MATERIALS IN BIOPHARMACEUTICAL MANUFACTURING
Chemical raw materials are used in multi-tons per batch during biopharmaceutical manufacturing. Managing such quantities in a pharmaceutical production environment can be challenging: Handling and weighing procedures can be time-consuming and costly. In addition, the formation of dust and caking/clu...

PHARMACEUTICAL FORENSICS FOR SAFE MANUFACTURING AND SUPPLY
PHARMACEUTICAL FORENSICS FOR SAFE MANUFACTURING AND SUPPLY
Pharmaceutical Investigations and Technology (PIT) is a group within Global Analytical Technology (GAT) department in the commercial Quality organization within Bristol-Myers Squibb. The PIT group has been a key part in BMS for 30 + years in providing analytical support for commercial manufacturing ...

Changing a Paradigm: Implementing a Real Time Microbial Detection Analyzer in Pharmaceutical Water
CHANGING A PARADIGM: IMPLEMENTING A REAL TIME MICROBIAL DETECTION ANALYZER IN PHARMACEUTICAL WATER
With the continued pressure to reduce costs through innovations and efficiencies all while delivering faster sample results, the use of an On-line Water Bioburden Analyzer (OWBA) is one way companies can meet these demands. OWBA technology has the flexibility to be used for purified water, water for...

Compliance Considerations for Pharmacy Sale or Acquisition
COMPLIANCE CONSIDERATIONS FOR PHARMACY SALE OR ACQUISITION
On Tuesday, June 18, 2019, our team of legal professionals and industry experts hosted a Compliance Considerations for Pharmacy Sale or Acquisition Webinar that took a look at the regulatory pitfalls and problems that can arise in a pharmacy transaction.

Building the Pharmaceutical Factory of the Future
BUILDING THE PHARMACEUTICAL FACTORY OF THE FUTURE
What is the Factory of the Future? It is a vision of a holistic company-wide transformation, which balances and combines: productivity, quality, and robustness based on a data-centric perspective. Is it possible to build the Pharma Factory of the Future today, increase quality and productivity, and ...

The Unsung Hero of Drug Discovery Kinetics
THE UNSUNG HERO OF DRUG DISCOVERY KINETICS
While the importance of ligand-receptor binding kinetics on drug action is becoming well established, focus to date has been almost entirely on the role of the dissociation constant on drug efficacy and duration of action.

Serialization 2.0 — Moving Beyond Compliance
SERIALIZATION 2.0 — MOVING BEYOND COMPLIANCE
Serialization is a great achievement for our industry. However, most executives now realize that it is only part of the solution, and serialization alone cannot solve the escalating problems of counterfeiting and diversion within the pharmaceutical industry. The global value of pharmaceutical counte...

Optimizing Clinical Trials for Commercial Success
OPTIMIZING CLINICAL TRIALS FOR COMMERCIAL SUCCESS
This webinar focuses on optimizing market access by integrating HTA and payer perspectives in development planning while preserving trial efficiency.

Applying Technology to New Science: Biopharma’s New Growth Engine
APPLYING TECHNOLOGY TO NEW SCIENCE: BIOPHARMA’S NEW GROWTH ENGINE
Today, there are clear signs that the biopharmaceutical industry is facing a quiet yet potentially damaging force: compressive disruption.  However, future-focused biopharma companies have found a way to deliver exceptional growth amidst compressive disruption: by embracing New Science, an ever...

From mg to kg: first steps towards a scalable process for drug substances
FROM MG TO KG: FIRST STEPS TOWARDS A SCALABLE PROCESS FOR DRUG SUBSTANCES
In this webinar, Anders Högdin, Senior Sales Director at Recipharm discusses the common challenges companies encounter during upscaling. He also outlines the key considerations during the medicinal and process chemistry planning phases, the regulatory requirements and the steps companies can ta...

CryoEM for Drug Discovery
CRYOEM FOR DRUG DISCOVERY
Cryo-electron microscopy (cryoEM) is a Nobel Prize-winning technique for solving high-resolution three-dimensional structures of biological molecules such as proteins, that is used for structure-based drug design. Key to the success of cryoEM are significant advances in high performance computer vis...

Increase Sensitivity and Reliability for Biopharmaceutical Applications by Simple Improvements in Sample Preparation
INCREASE SENSITIVITY AND RELIABILITY FOR BIOPHARMACEUTICAL APPLICATIONS BY SIMPLE IMPROVEMENTS IN SAMPLE PREPARATION
Sample preparation is an essential step for analytical chromatography, and recently biopharmaceutical analysts are discovering the need for cleaner, concentrated and targeted sample preparation methods for large molecules. This webcast will introduce how to properly clean up and isolate monoclonal a...

Best Process Best result Best Product Using Minitab for Superior Quality in the Pharmaceutical Industry.
BEST PROCESS BEST RESULT BEST PRODUCT USING MINITAB FOR SUPERIOR QUALITY IN THE PHARMACEUTICAL INDUSTRY.
Pharmaceutical manufacturers often have the task of reducing waste to meet company expectations, document the process to meet regulatory requirements and improve quality to meet customer specifications. Let's be honest, not achieving any of the above points is not an option in most pharmaceutica...

Overcoming Challenges in Ophthalmic Drug Delivery Including Bioavailability and Sterility
OVERCOMING CHALLENGES IN OPHTHALMIC DRUG DELIVERY INCLUDING BIOAVAILABILITY AND STERILITY
Delivery of therapeutics to the human eye is one of the most interesting—but challenging—endeavors a formulator can take on. The anatomy and chemical composition of the eye make it highly resistant to pharmaceutical penetration. Successfully circumventing these protective barriers requir...

Machine Learning for Patient Forecasting and Site Selection
MACHINE LEARNING FOR PATIENT FORECASTING AND SITE SELECTION
The clinical development marketplace continues to become more complex and competitive, with stricter regulatory standards and trial oversight—all the while demanding patient-centric drug development.  These, and other factors, contribute to  unsustainable costs and longer timelines b...

Progress and pitfalls in the AI-aided search for novel drugs
PROGRESS AND PITFALLS IN THE AI-AIDED SEARCH FOR NOVEL DRUGS
Artificial intelligence is changing how pharmaceutical companies operate, how they develop and study new treatments, and even what form those treatments take. Pharma companies are now pairing medicines with software — so-called digiceuticals powered by virtual reality and AI. Most of the world...

The science of smarter sampling for drug development
THE SCIENCE OF SMARTER SAMPLING FOR DRUG DEVELOPMENT
On Tuesday, June 25th, at 10:00 AM EDT, 4:00 PM CEST, Neoteryx, The Medicine Maker, and two leading blood microsampling experts present The Science of Smarter Sampling for Drug Development, an in-depth hour-long webinar covering the details of how to succeed with blood microsampling technology in th...

Planning Successful Launches of Complex Drug Products
PLANNING SUCCESSFUL LAUNCHES OF COMPLEX DRUG PRODUCTS
Developing and bringing a new drug to market is a long, expensive, and uncertain process. It’s even more complicated when it comes to complex products such as modified-release products and biologics. Bio/pharma companies can adopt proven strategies to increase the success of a product launch: ...

Patient-Focused Drug Design – A View from the R&D Front Lines
PATIENT-FOCUSED DRUG DESIGN – A VIEW FROM THE R&D FRONT LINES
Incorporation of patient-focused drug design principles is increasingly becoming essential to ensure that a new drug is commercially successful and delivers the best patient outcomes. Often, patient factors and insights are not considered or discovered until the later phases of drug development when...

NEW DRUG PRODUCT DEVELOPMENT USING CONTINUOUS MANUFACTURING
NEW DRUG PRODUCT DEVELOPMENT USING CONTINUOUS MANUFACTURING
Demonstrate finacial and operational benefits of Continuous Manufacturing. Explain the key challenges in the implementation of CM in R&D. Explore key strategies in drug product development of CM

NEW TOOLS TO ASSESS THE RISK OF MICROBIAL IMPURITIES IN THE PHARMACEUTICAL MANUFACTURING PROCESS
NEW TOOLS TO ASSESS THE RISK OF MICROBIAL IMPURITIES IN THE PHARMACEUTICAL MANUFACTURING PROCESS
Large-scale Production of Biologics is susceptible to microbial contamination because many manufacturing steps occur under non-sterile conditions in aqueous systems at ambient temperature or 2-8 °C under substantially neutral pH conditions. Regardless of where in the Drug Substance (DS) manufact...

Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019
PHARMA R&D REVIEW: WHAT CHANGED IN 2018, WHAT TO LOOK OUT FOR IN 2019
The drug R&D pipeline in 2019, and how it is changing

HHS OIG Proposed Rule on the Safe Harbor for Pharmaceutical Rebates: The Issues and Impact
HHS OIG PROPOSED RULE ON THE SAFE HARBOR FOR PHARMACEUTICAL REBATES: THE ISSUES AND IMPACT
In this on-demand webinar, we discuss the key takeaways of the proposed rule, including its potential impact, if finalized, on various stakeholders, including PBMs, health plans, drug manufacturers, and pharmacies.

The State of Pharmaceutical Regulatory Compliance: Global Changes and Challenges in Large Trading Regions
THE STATE OF PHARMACEUTICAL REGULATORY COMPLIANCE: GLOBAL CHANGES AND CHALLENGES IN LARGE TRADING REGIONS
Countries around the world continue to add serialization and track-and-trace requirements.  Additionally, countries that have already reached compliance deadlines continue to modify future timelines and conditions, creating uncertainty.

See the Impossible: Navigating Pharma Procurement in a Complicated World
SEE THE IMPOSSIBLE: NAVIGATING PHARMA PROCUREMENT IN A COMPLICATED WORLD
M&IW’s HMCC-certified buyers recently attended Pharma Forum and picked up the latest and greatest tips on sourcing healthcare meetings. In our next See the Impossible Webinar Series, learn how transparency, accountability and creative thinking can alleviate unnecessary back and forth and s...

Development Advice for CBD Products
DEVELOPMENT ADVICE FOR CBD PRODUCTS
Cannabadiol (CBD) products have been in news a lot recently, but what does it take to bring a CBD product to market for an unmet medical need? This webinar will discuss development considerations for CBD and other cannabis-derived products from a clinical, preclinical (pharmacology/toxicology), CMC,...

Terminal Sterilization or Aseptic Assembly? Consider all options for your Pharma product.
TERMINAL STERILIZATION OR ASEPTIC ASSEMBLY? CONSIDER ALL OPTIONS FOR YOUR PHARMA PRODUCT.
Regulation is clear that, whenever possible, products intended to be sterile should be terminally sterilized in their final container. Only if terminal sterilization is not possible, filtration or aseptic assembly should be applied. This webinar will focus on elements to evaluate prior to selecting ...

HME LIPIDIC PELLETS FOR PAEDIATRIC APPLICATION. AN INVESTIGATION OF THE EFFECT AND STABILITY ON DRUG DISSOLUTIONS
HME LIPIDIC PELLETS FOR PAEDIATRIC APPLICATION. AN INVESTIGATION OF THE EFFECT AND STABILITY ON DRUG DISSOLUTIONS
Hot Melt Extrusion (HME) is an established processing technology that can be used for the development of paediatric formulations. The processing of lipids via HME has been proved ideal for high drug loaded dosage forms with sustained release of drugs. The study investigates the effect of the lipid t...

Designing Amorphous Dispersion Formulations for Poorly Soluble Drugs
DESIGNING AMORPHOUS DISPERSION FORMULATIONS FOR POORLY SOLUBLE DRUGS
Many orally administered small molecules have low aqueous solubility, which leads to poor oral absorption. For many of these poorly soluble drugs currently in development, amorphous dispersions are increasingly being used as a formulation approach to improve solubility and oral absorption.

Targeted Cancer Chemotherapy: Developing NextGen Antibody-Drug Conjugates
TARGETED CANCER CHEMOTHERAPY: DEVELOPING NEXTGEN ANTIBODY-DRUG CONJUGATES
In today's presentation I will give an overview to developing NextGen ADCs. We will discuss everything from the beginning stages of development to the varying ADC combination therapies available

Biomarker Driven Drug Development
BIOMARKER DRIVEN DRUG DEVELOPMENT
Dramatic responses observed with targeted agents in the ‘right’ genomic context have fueled large scale sequencing efforts to identify ‘effective’ treatments for a given patient. In order to expeditiously evaluate a targeted agent against a potential ‘driver’ gene...

Solid Form Selection in Drug Development
SOLID FORM SELECTION IN DRUG DEVELOPMENT
Drug formulators should consider the physical properties of their products during pharmaceutical drug development. The physical properties of a solid drug substance are highly dependent on the solid form. It is critical to understand the solid form landscape and select the optimum solid form for dru...

APPLYING LOW FREQUENCY RAMAN TO QBD IN PHARMACEUTICAL DEVELOPMENT
APPLYING LOW FREQUENCY RAMAN TO QBD IN PHARMACEUTICAL DEVELOPMENT
Low frequency Raman spectroscopy has been used to study various polymorphs and can be applied to the design of crystallization control strategy. Extending the low frequency spectral region to include the fingerprint region provides access to collective vibrations of molecules in the amorphous and cr...

ANALYSING COMPLEX DATA IN THE PHARMACEUTICAL INDUSTRY: THE CASE FOR MULTIVARIATE ANALYSIS
ANALYSING COMPLEX DATA IN THE PHARMACEUTICAL INDUSTRY: THE CASE FOR MULTIVARIATE ANALYSIS
The Pharmaceutical Industry has a strong need to develop knowledge from data. Although the latter is not at a premium in the Pharmaceutical Industry the former is, as always, at a premium. Multivariate data analysis (MVA) is a set of statistical data analytical methods which has  been widely ad...

Improving Sterilising Filtration in the Biopharmaceutical Industry
IMPROVING STERILISING FILTRATION IN THE BIOPHARMACEUTICAL INDUSTRY
Sterile filtration has been a cornerstone of bioprocessing for over 60 years and as the industry continues its change from stainless steel to single-use, filtration has also evolved, moving from cartridge to capsule format with several membrane types to choose from. This webinar aims to provide an o...

A Structured Approach to Achieve Shorter Drug Discovery Cycletimes
A STRUCTURED APPROACH TO ACHIEVE SHORTER DRUG DISCOVERY CYCLETIMES
Biotechs have limited funding, and their investors must regularly be shown constant tangible project progress in the Drug Discovery phase. Biotechs whose projects lag, have their funding and future at risk. Likewise, large pharma must continually re-prioritize its portfolio of Discovery projects, an...

Why are Lipid Formulations Commonly Used to Enhance Bioavailability?
WHY ARE LIPID FORMULATIONS COMMONLY USED TO ENHANCE BIOAVAILABILITY?
Enabling formulations becomes more and more necessary to obtain adequate exposure of APIs during (pre)-clinical research. Currently, most registered formulations to improve bioavailability are based on lipidic systems, which make use of intrinsic digestion processes within the GI tract, facilitating...

New Drug Pricing Strategies for a Changing Global Market
NEW DRUG PRICING STRATEGIES FOR A CHANGING GLOBAL MARKET
Biopharmaceutical companies are increasingly challenged to create a drug pricing strategy that both rewards value and innovation, and promotes affordability and access. During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, an...

Managing Risk and Opportunity for Immediate- and Modified-Release Drug Formulations
MANAGING RISK AND OPPORTUNITY FOR IMMEDIATE- AND MODIFIED-RELEASE DRUG FORMULATIONS
Formulators modify the release profiles of drugs for multiple reasons: to target delivery of the API, enhance bioavailability, provide dosage convenience, improve patient adherence, and extend the patentable life cycle of an existing drug.Whether the desired profile is for immediate or modified rele...

Top 4 Quality Trends for 2019 Pharma Quality Outlook Survey
TOP 4 QUALITY TRENDS FOR 2019 PHARMA QUALITY OUTLOOK SURVEY
Economic performance could soon replace compliance as the leading quality goal for pharmaceutical companies.
According to the 2019 Pharma Quality Outlook Survey, 66% of industry executives named compliance as a top goal, down 10% from last year. Meanwhile, more than one-third (39%) say that e...

Ensuring Integrity of Drug Formulation from Development to QC
ENSURING INTEGRITY OF DRUG FORMULATION FROM DEVELOPMENT TO QC
After a small molecule has been identified as a viable drug candidate, substantial testing is required to assure that chemical and structural integrity are preserved throughout the drug development process to maintain its functionality. To keep a balance between quality and manufacturability, time-c...

Designing Amorphous Dispersion Formulations for Poorly Soluble Drugs
DESIGNING AMORPHOUS DISPERSION FORMULATIONS FOR POORLY SOLUBLE DRUGS
In this webcast, participants will learn about best practices for designing successful amorphous dispersion formulations with respect to manufacturability, performance, and stability along with several case studies to illustrate various types of drugs and problem statements.

Raman Spectroscopy for Streamlining Testing and Reducing Costs in Pharma QC and Formulation Development
RAMAN SPECTROSCOPY FOR STREAMLINING TESTING AND REDUCING COSTS IN PHARMA QC AND FORMULATION DEVELOPMENT
This webcast will describe the use of Raman spectroscopy techniques for improving the speed and efficiency of pharmaceutical testing. In the first of two presentations, transmission Raman is discussed as an alternative, non-destructive method for product release testing, working alongside HPLC to si...

Sustainable Sourcing & Supply Chain Engagement in Pharma
SUSTAINABLE SOURCING & SUPPLY CHAIN ENGAGEMENT IN PHARMA
Various aspects of the pharma sourcing process and supplier relationships offer opportunities to advance sustainability and strategic goals. These include alternative raw materials at manufacturing facilities (e.g., biomass and recycled plastic), sourcing of renewable materials (e.g., palm oil), par...

Biophysical and Stability Characterization of Antibody-Drug Conjugates
BIOPHYSICAL AND STABILITY CHARACTERIZATION OF ANTIBODY-DRUG CONJUGATES
Antibody-Drug Conjugates (ADCs) are a rapidly growing class of oncology therapeutics wherein a potent cytotoxic drug is conjugated to the antibody molecule. The impact of drug conjugation on the antibody's conformation needs to be evaluated.

The Kinetics of Drug Binding
THE KINETICS OF DRUG BINDING
Optimizing the receptor binding kinetics of new drugs can have significant benefits, ranging from improved duration of action to enhanced efficacy through the insurmountable antagonism of dynamic physiological systems.

Label-Free Techniques for Drug Discovery: Surface Plasmon Resonance (SPR) and MALDI Mass Spectrometry for Primary (HTS) and Secondary Screening
LABEL-FREE TECHNIQUES FOR DRUG DISCOVERY: SURFACE PLASMON RESONANCE (SPR) AND MALDI MASS SPECTROMETRY FOR PRIMARY (HTS) AND SECONDARY SCREENING
The webinar will update on latest developments in MALDI mass spectrometry for high-throughput screening and CPD profiling (rapifleX MALDI PharmaPulse) and introduce Bruker's new surface plasmon resonance (SPR) instrument, the SIERRA SPR-32. Beside technical details explaining the latest developm...

Current Trends in Laboratory Spray Drying Within the Pharmaceutical Industry
CURRENT TRENDS IN LABORATORY SPRAY DRYING WITHIN THE PHARMACEUTICAL INDUSTRY
Spray drying is one of the most remarkable technologies currently to be applied to pharmaceuticals. It is a continuous process that converts, in a single step, a liquid feed into a powder and is an ideal process when precise attributes such as particle size, morphology and stability are required.

Overcoming Manufacturing Challenges for Accelerated Development
OVERCOMING MANUFACTURING CHALLENGES FOR ACCELERATED DEVELOPMENT
The pharmaceutical industry has experienced a trend in the number of accelerated approval designations for drugs (e.g. orphan drugs, breakthrough therapies, accelerated approvals, and FDA priority reviews) being developed. These designations are given shortened timelines for product development, pro...

The State of Pharmaceutical Regulatory Compliance
THE STATE OF PHARMACEUTICAL REGULATORY COMPLIANCE
To keep their products in the marketplace, pharma brands must stay up to date on global regulatory changes.

PHARMACEUTICAL HOT MELT EXTRUSION A COST EFFECTIVE METHOD TO INCREASE SOLUBILITY
PHARMACEUTICAL HOT MELT EXTRUSION A COST EFFECTIVE METHOD TO INCREASE SOLUBILITY
In the last 20 years Hot Melt Extrusion (HME) has seized the attention of pharmaceutical industry for the development of pharmaceutical solid dispersions. It is a versatile processing technology, which can effectively increase the solubility/dissolution of water insoluble active pharmaceutical ingre...

Brexit: Separating Fact From Fiction
BREXIT: SEPARATING FACT FROM FICTION
The impact of Brexit on the life sciences industry: separating fact from fiction to prepare for the impact of a change in the relationship between the UK and EU.

Speed, Quality & Cost – Why You Should be Conducting Your Clinical Trials in Australia
SPEED, QUALITY & COST – WHY YOU SHOULD BE CONDUCTING YOUR CLINICAL TRIALS IN AUSTRALIA
Speed, Quality & Cost – Why You Should be Conducting Your Clinical Trials. Join PCI Clinical Services and their partners for this educational webinar to learn tax incentive program and eligibility when conducting your trials in Australia

Big Pharma Outlook 2026
BIG PHARMA OUTLOOK 2026
Datamonitor Healthcare’s Pharmavitae Analytics team casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals.

Neuromodulation Device Market Innovations and Trends
NEUROMODULATION DEVICE MARKET INNOVATIONS AND TRENDS
Explore the area of neuromodulation, which is seeing significant growth at a time when other medical device markets are facing declining growth. The team focus on three targeted neuromodulation areas, including: spinal cord stimulation (SCS), deep brain stimulation (DBS) and vagus nerve stimulation ...

Key Catalysts and their Impact on Pharma Markets
KEY CATALYSTS AND THEIR IMPACT ON PHARMA MARKETS
Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets". During this important sessi...

Realizing The Opportunity To Increase Quality And Improve Efficiency Of Safety Data Collection Within Patient Support Programs
REALIZING THE OPPORTUNITY TO INCREASE QUALITY AND IMPROVE EFFICIENCY OF SAFETY DATA COLLECTION WITHIN PATIENT SUPPORT PROGRAMS
Patient Support Programs (PSPs) have changed dramatically over the past decade; they have become global activities, and grown significantly in scale and complexity. While PSPs are also an increasingly valuable resource for pharmacovigilance due to the extensive patient safety data they generate, the...

Improve ultrapure water system performance and uptime with ozone
IMPROVE ULTRAPURE WATER SYSTEM PERFORMANCE AND UPTIME WITH OZONE
This webinar is designed to help companies understand the application and benefit of ozone technology in ultrapure water systems and how ozone solutions can improve water system performance, uptime and product quality in pharmaceutical manufacturing applications.

Integrated pharma manufacturing – It works
INTEGRATED PHARMA MANUFACTURING – IT WORKS
This webinar focuses on the benefits of integrated pharma manufacturing using examples of integrated processing and packaging solutions. The webinar also highlights the key advantages of choosing a single pharma solutions provider for all manufacturing needs.

Let’s talk TOC and conductivity requirements for pharmaceutical water systems
LET’S TALK TOC AND CONDUCTIVITY REQUIREMENTS FOR PHARMACEUTICAL WATER SYSTEMS
This webinar addresses the requirements for continuous monitoring of water for injection (WFI) systems and how this can be achieved with total organic carbon (TOC) and conductivity. It will also cover cold WFI production according to EP and how it applies to water systems.

Facilitating Drug Discovery with HDX-Mass Spectrometry
FACILITATING DRUG DISCOVERY WITH HDX-MASS SPECTROMETRY
Scientists are always on the hunt for new analytical approaches that will streamline the biotherapeutic characterization process and answer questions found intractable using traditional methodologies. One such technique, hydrogen deuterium exchange mass spectrometry (HDX-MS)—a biophysical tool...

Patient-Focused Drug Design
PATIENT-FOCUSED DRUG DESIGN
Incorporation of patient-focused drug design principles is increasingly becoming essential to ensure that a new drug is commercially successful and delivers the best patient outcomes. Often, patient factors and insights are not considered or discovered until the later phases of drug development when...

The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan
THE 2ND LIFE SCIENCES SECTOR DEAL AND THE NHS 10 YEAR PLAN
Brexit uncertainty isn’t going away any time soon – but it’s important to remember that the UK government has already set out two plans for the future shape of the country’s healthcare industry: the second Life Sciences Sector Deal and the long-term plan for the NHS. With the...

Purity determination of pharmaceuticals by thermal analysis
PURITY DETERMINATION OF PHARMACEUTICALS BY THERMAL ANALYSIS
Differential Scanning Calorimetry (DSC) is the most widely used thermal analysis technique. A well-established application is the purity determination of organic substances. The method is based on the van’t Hoff law of melting point depression of eutectic systems. Purities between 90 and 100 m...

Combating Drug Diversion and Counterfeiting in a Post-Serialization Landscape
COMBATING DRUG DIVERSION AND COUNTERFEITING IN A POST-SERIALIZATION LANDSCAPE
In this 45-minute webinar, industry experts discuss the dangers of stopping at compliance and explore the opportunities to maximize your serialization investment for true supply chain security.

Maximizing the Value of Your Drug Development Program
MAXIMIZING THE VALUE OF YOUR DRUG DEVELOPMENT PROGRAM
This webinar will benefit executives at Biotech and Pharmaceutical companies interested in learning more about 505(b)(2) drug development and how to save time and money while maximizing the value of their drug development program.

3DP Dosage Forms and the Future of Drug Lifecycle Management
3DP DOSAGE FORMS AND THE FUTURE OF DRUG LIFECYCLE MANAGEMENT
Pharmaceutical companies and their drugs face numerous challenges in the brief window between launch and patent expiration. This makes it extremely important to plan lifecycle management (LCM) strategies well in advance of patent expiry. One way to address this is with advanced manufacturing techniq...

Pharmaceutical Impurities
PHARMACEUTICAL IMPURITIES
Hear how you can optimize your impurity analysis workflows to obtain greater productivity, sensitivity, accuracy and reproducibility to meet increasing regulatory requirements and lower limits of detection. Learn how to achieve all of this, whilst also increasing laboratory efficiency and reducing t...

Authentication empowerment.: What it takes to fight counterfeit drugs
AUTHENTICATION EMPOWERMENT.: WHAT IT TAKES TO FIGHT COUNTERFEIT DRUGS
Join Authentix and David Howard, former Director of Johnson & Johnson Global Brand Protection, to discuss the counterfeit challenges and how to address them through strategic planning and implementation.

Pharmaceutical quality control: Connecting with your supply chain!
PHARMACEUTICAL QUALITY CONTROL: CONNECTING WITH YOUR SUPPLY CHAIN!
When it comes to the Pharma supply chain, problems can occur at any part of the process, including non-standardized bills of material, translation mistakes, typos and poor proofreading, missed annotations, unclear briefs, artwork problems, expired digital assets, third-party artwork suppliers and pr...

Control-Alter-Delete: Epigenetic Regulation by Non-Coding RNAs in Neuronal Systems Webinar
CONTROL-ALTER-DELETE: EPIGENETIC REGULATION BY NON-CODING RNAS IN NEURONAL SYSTEMS WEBINAR
Listen in as Dr Jeremy Day, of the Department of Neurobiology at the University of Alabama at Birmingham, discusses his work exploring non-coding RNA species regulation of DNA methylation in neuronal system- including a review of some of his lab's latest unpublished data.

Optimizing eConsent for Patient Centricity
OPTIMIZING ECONSENT FOR PATIENT CENTRICITY
Most informed consent forms are not patient focused and do not support the needs of the study participant! Use of electronic consent can help improve the current paper document approach, but there is more to it than just replacing paper with a multi-media eConsent. What does it take to make eConsent...

Host Cell Protein Analysis by Mass Spectrometry
HOST CELL PROTEIN ANALYSIS BY MASS SPECTROMETRY
The analysis of Host Cell Proteins (HCPs) has historically been performed using ELISA-based tests. A number of off-the-shelf products (e.g. Cygnus kits) are available and the testing is relatively straightforward. However, it been recognized for some time that these kits generally allow detection of...

Proving the strategic value of patients
PROVING THE STRATEGIC VALUE OF PATIENTS
On the 10th October Cello Health Insight, in association with PMGroup, will look at the value of three areas of patient research that provide that ‘must have’ understanding: mapping the patient pathway, patient motivation and the dialogue between patient and HCP.

The Truth about Doctors
THE TRUTH ABOUT DOCTORS
Amidst the massive technological and social changes upending the societal status quo, the culture of doctors around the globe is also in flux according to The Truth About Doctors, a new global research study conducted by McCann Health, in partnership with McCann Truth Central. This landmark study wh...

Optimizing Oncology Trials with a ctDNA Test
Custom-Built for MRD and Molecular Monitoring
OPTIMIZING ONCOLOGY TRIALS WITH A CTDNA TEST CUSTOM-BUILT FOR MRD AND MOLECULAR MONITORING
Join this webinar to discover the advantages of using Signatura™ (RUO), a novel assay custom-designed for each patient that detects circulating tumour DNA (ctDNA) with high sensitivity and specificity to monitor molecular residual disease, early recurrence, and treatment response across solid ...

Innovative OTC Remedies for Seasonal Flu Epidemic
INNOVATIVE OTC REMEDIES FOR SEASONAL FLU EPIDEMIC
It was reported that over 79,000 people died of flu in the U.S. in the winter of 2017-2018, which was the highest death toll in four decades.1 It seems like the 2018-2019 flu season isn’t so bad.  How are sales of OTC drugs impacted by the severity of flu seasons?  Are there any oppo...

The Product Development Superhighway
THE PRODUCT DEVELOPMENT SUPERHIGHWAY
Pharmaceutical and biotechnology companies value streamlined services from early-phase development to clinical supply services to commercialization. These services not only provide with improved efficiencies, such as the ease of transition from one development phase to the next, but also remove the ...

Overcoming Drug Resistance Patterns in Non-Responders: Proven Best Practices on Informing Your Clinical Strategy
OVERCOMING DRUG RESISTANCE PATTERNS IN NON-RESPONDERS: PROVEN BEST PRACTICES ON INFORMING YOUR CLINICAL STRATEGY
Many standard of care (SOC) treatments in cancer patients result in a clinical outcome of non-response. Drug development companies are trending toward interrogating resistance mechanisms and using this information in advancing their programs and informing personalized approaches to novel therapeutic...

Regulatory Strategies for the Analytical Development of New Biological Entities and Biosimilars
REGULATORY STRATEGIES FOR THE ANALYTICAL DEVELOPMENT OF NEW BIOLOGICAL ENTITIES AND BIOSIMILARS
The webinar will focus on the relationship between analytics of biotherapeutic products and the interpretation of data to build and support a solid regulatory Chemistry, Manufacturing and Control (CMC) strategy. The importance of data interpretation is illustrated in the development of biosimilars a...

Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know
USING REAL-WORLD EVIDENCE FOR U.S. REGULATORY DECISION-MAKING: WHAT PHARMA NEEDS TO KNOW
We are entering a new era in which real-world evidence is transforming how drugs are developed, approved, and commercialized. As FDA leads the change with a 3-year strategy—the Framework for FDA’s Real-World Evidence Program—the industry is launched on a shared learning process to ...

Patient Adherence: A Hard Pill to Swallow?
PATIENT ADHERENCE: A HARD PILL TO SWALLOW?
The pill-taking experience has a direct impact on patient acceptance and adherence to a prescription regimen; which in turn can impact a drug’s overall effectiveness. Patients that report having difficulty swallowing tablets are far more likely to skip, discontinue, or delay a dose. Every miss...

Cell Biology 2017
CELL BIOLOGY 2017
Join us in advancing basic biology and recent tools and techniques in cell research by coming together with like-minded colleagues. Cell Biology 2017 creates a valuable platform for inspiring global and interdisciplinary collaboration in a virtual environment. The Conference will bring together prof...

Designing Pharma organisations for success
DESIGNING PHARMA ORGANISATIONS FOR SUCCESS
Across all industries, people are changing the ways they engage with products, services, and brands. As a result, life sciences companies find themselves challenged to compete for mindshare in an increasingly noisy market. To stay relevant, pharma marketers must re-evaluate their traditional commerc...

Applying quality risk management to develop an isolator filling line
APPLYING QUALITY RISK MANAGEMENT TO DEVELOP AN ISOLATOR FILLING LINE
Following the patent of the innovative “Espresso” intravenous delivery device, the Italian Biochemical Institute (IBI) “Lorenzini” commissioned Comecer to construct a filling line to meet the unique requirements of the solution. Particle Measuring Systems’ advisory team...

How To Develop Fully Compliant Electronic Drug Delivery Devices
HOW TO DEVELOP FULLY COMPLIANT ELECTRONIC DRUG DELIVERY DEVICES
Using electronics today is a part of our daily lives. It is almost impossible to imagine how the world would be without electronics. The healthcare industry is not an exception to this. The drive towards having connected healthcare has become a well-established facet of current drug delivery device ...

Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets
Q1 OUTLOOK WEBINAR: KEY CATALYSTS AND THEIR IMPACT ON PHARMA MARKETS
Find out which market-moving events and catalysts to watch for during the upcoming Q1 Outlook Webinar - Key catalysts and their impact on pharma markets. During this webinar recording, industry analysts from Informa Pharma Intelligence  present their data-based views on what’s in store fo...

The Role of Technology in Precision Diagnosis
THE ROLE OF TECHNOLOGY IN PRECISION DIAGNOSIS
Individualized, precision medicine is an evolving medical model and is key in helping clinicians reach accurate diagnoses and effective treatment plans for many patients. There are much promise and hype around precision medicine, but implementing and scaling a precision medicine program is challengi...

Document Imaging and Medical Record Management
DOCUMENT IMAGING AND MEDICAL RECORD MANAGEMENT
Many Health Information Management departments are still prepping charts that come from all departments of a hospital system. This means that there is a potential time lag in making this critical information available to providers. The first place to start is selecting a document imaging solution fo...

How to Leverage Clinical IRT to Improve Clinical Trial Efficiency
HOW TO LEVERAGE CLINICAL IRT TO IMPROVE CLINICAL TRIAL EFFICIENCY
In this live webinar, our featured speaker will focus on the many attributes that must be considered to improve your clinical trial efficiency and experience. Participants will learn how to use the information you have from the protocol and clinical trial knowledge, along with clinical IRT expertise...

Gaining critical insights for drug discovery applications using high-content cell analysis platforms
GAINING CRITICAL INSIGHTS FOR DRUG DISCOVERY APPLICATIONS USING HIGH-CONTENT CELL ANALYSIS PLATFORMS
Gain insights from an assay development expert as Dr. David Baker, of AstraZeneca, discusses how you can enable rapid measurement of cell proliferation, transfection efficiency, cell confluence and other cellular characteristics for assay optimization using live-cell imaging and high throughput flow...

PATIENT SATISFACTION: THE LABORATORY
PATIENT SATISFACTION: THE LABORATORY'S ROLE IN CARING FOR AND SERVING PATIENTS
Hospitals are continually adapting to new models of care and payment, the success of which is often measured at least in part by overall patient satisfaction. Patient satisfaction comes from a multitude of areas affected by nearly everyone on the care team, and the medical laboratory lies at an impo...

Deciphering fibrosis: Exploring the biological drivers of fibrotic disease in the liver and heart
DECIPHERING FIBROSIS: EXPLORING THE BIOLOGICAL DRIVERS OF FIBROTIC DISEASE IN THE LIVER AND HEART
Fibrotic diseases of the heart and liver impact a significant portion of the global population and are a growing public health concern. Fibrosis occurs when fibroblasts deposit excess extracellular material within the tissue in response to certain stimuli or injury. Myocardial fibrosis is associated...

Getting started in 3D - Setting up your lab and reviewing common pitfalls of researchers new to 3D
GETTING STARTED IN 3D - SETTING UP YOUR LAB AND REVIEWING COMMON PITFALLS OF RESEARCHERS NEW TO 3D
As we develop new methods to create more biologically relevant models for research in understanding disease etiology and innovating new treatment options, one of the most requested areas for educational materials is 3D cell models such as organoid and spheroid systems. Thermo Fisher Scientific is pr...

UNDERSTANDING THE PROPENSITY OF SEQUENCE VARIANTS DURING CELL LINE AND CULTURE PROCESS DEVELOPMENT
UNDERSTANDING THE PROPENSITY OF SEQUENCE VARIANTS DURING CELL LINE AND CULTURE PROCESS DEVELOPMENT
Sequence variants (SVs) are protein isoforms that contain one or more unintended amino acid substitutions. They can arise at a single amino acid site due to a genetic (RNA/DNA) mutation or at multiple amino acid locations, potentially due to translational errors, also referred to as misincorporation...

Breaking the Wall of Cyberattacks: How Cybersecurity Research Defends Our Critical Infrastructures
BREAKING THE WALL OF CYBERATTACKS: HOW CYBERSECURITY RESEARCH DEFENDS OUR CRITICAL INFRASTRUCTURES
Digitalization pervades every aspect of our daily lives. Technological advances empower us, but also make us extremely vulnerable. In this talk, renowned expert Sadie Creese will explore the most pressing cybersecurity challenges of the 21st century

Gene Therapy for Rare Diseases: Considerations for Both Clinical and Post-Marketing Studies
GENE THERAPY FOR RARE DISEASES: CONSIDERATIONS FOR BOTH CLINICAL AND POST-MARKETING STUDIES
There are approximately 7,000 distinct rare diseases affecting 350 million people worldwide, approximately 80 percent of which are caused by faulty genes. Scientific advances such as the CRISPR/Cas9 genome-engineering system have simplified the pharmaceutical and biotech industry’s ability to ...

A Novel Approach to ALS Trial Development
A NOVEL APPROACH TO ALS TRIAL DEVELOPMENT
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder affecting some 40,000 individuals in Europe at any time, causing 10,000 deaths each year. As with other age-related neurodegenerative diseases, the drug development field is littered with inconclusive or negative trials. Modifying I...

Cell and Gene Therapies for Cancer: Future Promises and Challenges
CELL AND GENE THERAPIES FOR CANCER: FUTURE PROMISES AND CHALLENGES
The field of immuno-oncology has exploded in the clinic, in the press, and on Wall Street, particularly regarding the use of genetically modified immune cells to fight cancer. This “explosion” is largely due to the success of chimeric antigen receptor (CAR) T-cell therapy. The fields of ...

A Comprehensive Review of Biomarker Endpoints in In Vivo Models of Parkinson’s Disease
A COMPREHENSIVE REVIEW OF BIOMARKER ENDPOINTS IN IN VIVO MODELS OF PARKINSON’S DISEASE
Therapeutic approaches for Parkinson’s disease are either focused on disease modification (a-synuclein or MPTP models) or symptom management (haloperidol or 6-OHDA models). Therapeutic approaches for Parkinson’s disease are either focused on disease modification (a-synuclein or MPTP mode...

A Blueprint for Translational Integrated Drug Discovery
A BLUEPRINT FOR TRANSLATIONAL INTEGRATED DRUG DISCOVERY
What does the future of your drug discovery program look like? Many industry leaders are finding themselves in uncharted waters: the science is more sophisticated than ever, producing paradigm-altering treatments. But, historically high R&D costs and low success rates has emphasized the need to ...

BPOG RISK-BASED APPROACHES TO USE OF CLOSED SYSTEMS IN RENOVATIONS OF EXISTING BIOPHARMA API FACILITIES
BPOG RISK-BASED APPROACHES TO USE OF CLOSED SYSTEMS IN RENOVATIONS OF EXISTING BIOPHARMA API FACILITIES
Companies often experience regulatory challenges during an inspection of aging facilities, requiring them to initiate projects to optimize product protection and updating to current standards for classified areas for biopharma manufacturing. For a long time, the company response has been to improve ...

EU Medical Device Regulation: Your Questions Answered
EU MEDICAL DEVICE REGULATION: YOUR QUESTIONS ANSWERED
This webinar will address these and other critical questions and will pave the way to strategic planning for compliance with the EU MDR. New product development teams will discover that the timeline for MDR is extremely limited compared to existing products on the market. Post-market surveillance te...

The Heart of Addiction: A Revolutionary New Understanding of Addiction and Its Treatment
THE HEART OF ADDICTION: A REVOLUTIONARY NEW UNDERSTANDING OF ADDICTION AND ITS TREATMENT
In this on-demand webinar, you will be learning a new way to both understand and treat addiction - a way that has been revolutionizing the field. Described by scholars and clinicians as masterful, pioneering and courageous, this new approach has enabled successful treatment of patients who have been...

Preventing Readmissions Through Quality Healthcare
PREVENTING READMISSIONS THROUGH QUALITY HEALTHCARE
Gain a better understanding of quality health care and improved patient outcomes based on the quality of care. Health care is quickly becoming a commodity. The increased focus on quality by CMS and other payer sources has driven the need to create effective strategies to control costs. One such stra...

Drug Manufacturing Analytics – Making the Complex Simple
DRUG MANUFACTURING ANALYTICS – MAKING THE COMPLEX SIMPLE
Typically, Manufacturing Operations and Support Personnel spend too much time trying to navigate a complex information landscape to locate data, extract it and combine it with data from other systems to gain insights about the assets and drug manufacturing processes they support and service. At Eli ...

How Advanced Therapies are Changing the Landscape of Rare Disease
HOW ADVANCED THERAPIES ARE CHANGING THE LANDSCAPE OF RARE DISEASE
After years of innovative research, advanced therapies are dramatically changing the way patients are treated for a wide variety of diseases particularly for patients with rare diseases and orphan indications. New developments in advanced therapy medicinal products (ATMPs) comprising cell and gene t...

Osteosarcoma research
OSTEOSARCOMA RESEARCH
Osteosarcoma is the most common type of primary bone cancer affecting adolescents and children attributed to rapid bone growth and turnover with a peak incidence at 18 years old. it is a rare incurable and often fatal disease. The current osteosarcoma treatments include standard chemotherapy, limb s...

Optimizing GI Testing: Molecular Diagnostic Testing for Common Stool Pathogens
OPTIMIZING GI TESTING: MOLECULAR DIAGNOSTIC TESTING FOR COMMON STOOL PATHOGENS
Over the past few years, the gastroenterology diagnostic market has witnessed an increase in commercial multiplex diagnostic assays for the detection of a large array of enteric pathogens. These multiplex assays differ in many aspects, one important difference being the number of enteric pathogens t...

Operationalizing Data Science Models in Healthcare
OPERATIONALIZING DATA SCIENCE MODELS IN HEALTHCARE
As healthcare organizations are becoming more adept at developing models, the ability and required skills to manage, validate, and deploy those models efficiently remain a challenging task. This webinar will present an overview and history of this process, along with tools and techniques that can he...

Make the Most of Azure DevOps in Healthcare
MAKE THE MOST OF AZURE DEVOPS IN HEALTHCARE
With Microsoft Azure DevOps, healthcare IT teams get a combination of processes, industry best practices and proven tools to make the most of their DevOps initiatives. The webinar discusses how organizations can leverage it to accelerate DevOps implementation.

Are All Neurodegenerative Diseases Made Equal?
ARE ALL NEURODEGENERATIVE DISEASES MADE EQUAL?
Various neurodegenerative processes result in the development of diseases like Alzheimer’s (AD), Parkinson’s (PD), amyotrophic lateral sclerosis (ALS), and, arguably, multiple sclerosis (MS). Despite years of research, drug discovery initiatives, and promising clinical trials, these dise...

Genetic Variant Detection in Cancer: Using ISH to Track Tumor Evolution
GENETIC VARIANT DETECTION IN CANCER: USING ISH TO TRACK TUMOR EVOLUTION
Intratumor heterogeneity (ITH) is a major underlying cause of therapy resistance and disease recurrence and is a read-out of how a tumor has grown. Current methods to analyze genetic ITH rely on the sequencing of ‘bulk’ or flow-sorted populations, in which the spatial context of tumor su...

Clinical and Genetic Determinants of Contralateral Breast Cancer in Newly Diagnosed Breast Cancer Patients
CLINICAL AND GENETIC DETERMINANTS OF CONTRALATERAL BREAST CANCER IN NEWLY DIAGNOSED BREAST CANCER PATIENTS
This webinar will review clinical and genetic risk factors for contralateral breast cancer in patients who have been newly diagnosed with breast cancer. A specific focus on the role of family history and genetic mutations on contralateral breast cancer risk will be outlined. The role of risk models ...

Integrating Polygenic and Monogenic Germline Testing Results Into Prostate Cancer Risk Assessment
INTEGRATING POLYGENIC AND MONOGENIC GERMLINE TESTING RESULTS INTO PROSTATE CANCER RISK ASSESSMENT
In this webinar, Dr. Xu will summarize recent data on inherited risk for prostate cancer, including germline mutations in high-penetrance genes (HPGs), risk-associated SNPs, and SNP-based genetic risk score (GRS). He will present detailed data supporting the broad-sense validity of GRS in risk asses...

Bridging the gap between ortho and restorative treatment
BRIDGING THE GAP BETWEEN ORTHO AND RESTORATIVE TREATMENT
The practitioner who wishes to get started in GDP orthodontics faces a bewildering array of choices: clear aligners or fixed appliances? Which product is best to get started with? How to overcome one’s poor foundation of orthodontic knowledge from undergraduate training, when much of the infor...

Studies of Mosquito Immunology and Plasmodium Virulence Using Imaging Flow Cytometry
STUDIES OF MOSQUITO IMMUNOLOGY AND PLASMODIUM VIRULENCE USING IMAGING FLOW CYTOMETRY
The classification of mosquito blood cells is controversial, complicated by the small size and number of cells one can obtain per mosquito, by the autofluorescent debris found in hemolymph, and the tendency of phagocytes to take up this autofluorescent debris. Much of the classification has been per...

Beckman Coulter Life Sciences Virtual Trade Show
BECKMAN COULTER LIFE SCIENCES VIRTUAL TRADE SHOW
We developed this platform to help you learn about our products, solutions and applications expertise on your own terms. Each booth contains valuable resources in the form of application notes, white papers, scientific posters, and other materials. We encourage you to review and download as much as ...

SyncD³ - Where drug discovery & development meet
SYNCD³ - WHERE DRUG DISCOVERY & DEVELOPMENT MEET
This first of its kind online scientific conference brings the world of drug discovery and development to your desk or lab bench.  You are free to choose the talks most relevant to your research to customize a conference experience that meets your needs. Cutting edge topics in the sessions will...

Understanding the Changes in Healthcare and Clinical Lab Marketplace
UNDERSTANDING THE CHANGES IN HEALTHCARE AND CLINICAL LAB MARKETPLACE
This session will discuss current changes in the laboratory testing marketplace and the impact on healthcare. Major trends will be discussed specific to physician practice, reimbursement, government programs, and patient care. Opportunities for clinical laboratories and pathology groups to add value...

Unusual Cases: Bridging Hematology and Flow Cytometry
UNUSUAL CASES: BRIDGING HEMATOLOGY AND FLOW CYTOMETRY
Multiparameter flow cytometry has become an integral tool in the workup of abnormal WBC findings, allowing for rapid and accurate identification of abnormal cell populations, cell lineage assignment, and assessment of clonality. This presentation will discuss a series of cases that demonstrate the u...

Best Practices for Protecting Against Malpractice Claims
BEST PRACTICES FOR PROTECTING AGAINST MALPRACTICE CLAIMS
Medical malpractice cases are expensive and becoming harder to defend so it is more imperative than ever to be proactive and avoid them. What specifically can health systems do to limit potential exposure? Learn these answers from a nationally recognized and seasoned defense attorney. The informatio...

Initial Evaluation and Treatment for a Burn Patient
INITIAL EVALUATION AND TREATMENT FOR A BURN PATIENT
Learn more on burn injury, prevention and the immediate care needed for patients with burn injuries. In the United States, approximately 486,000 people seek medical treatment for burns each year. Many people may not recognize their risk of burn injury. This material will review burn injuries, includ...

Cancer Research & Oncology 2018
CANCER RESEARCH & ONCOLOGY 2018
Our 6th Annual Cancer Research & Oncology Virtual Event is now available On Demand! This free online event will bring research professionals, scientists, and clinicians from around the world to learn and discuss recent advances in cancer research. As with all LabRoots events, the Cancer Research...

BioProcessing 2019
BIOPROCESSING 2019
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) credits. To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular ...

Complementary Detection of Somatic Variants from Tumor Tissue and Plasma Samples Using AVENIO Analysis Kits
COMPLEMENTARY DETECTION OF SOMATIC VARIANTS FROM TUMOR TISSUE AND PLASMA SAMPLES USING AVENIO ANALYSIS KITS
The AVENIO Tumor Tissue Targeted Kit is a next-generation sequencing (NGS) assay for comprehensive genomic profiling of solid tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples.  It contains 17 guideline-aligned biomarkers, including those in the U.S. National Comprehensive Canc...

Robust library preparation for improved ultra-low input and flexible single-cell RNA-sequencing
ROBUST LIBRARY PREPARATION FOR IMPROVED ULTRA-LOW INPUT AND FLEXIBLE SINGLE-CELL RNA-SEQUENCING
The science of medicine has allowed us to make incredible advances in diagnosing and treating diseases. But the complexity of human biology is staggering. Every person is unique and in many ways, so are diseases. Yet the digital revolution in healthcare provides new ways to both collect high-quality...

Using Real World Evidence to Build Dynamic Cohorts in Real-Time
USING REAL WORLD EVIDENCE TO BUILD DYNAMIC COHORTS IN REAL-TIME
After the US Food and Drug Administration (FDA)’s stated that “the clinical trial system is broken,” regulatory agencies began working to formally figure out how real-world evidence will be used in new drug submissions and for new uses of existing drugs. The business potential is h...

Validating Configurable Interactive Response Technology Solutions for Clinical Studies
VALIDATING CONFIGURABLE INTERACTIVE RESPONSE TECHNOLOGY SOLUTIONS FOR CLINICAL STUDIES
In this webinar, the validation of an interactive response technology (IRT) solution built with configurable parameters will be explored. Traditionally, interactive response technology solutions require validation of each study-specific requirement to ensure proper implementation. With the prevalenc...

How to get speed and depth in your Host Cell Protein (HCP) analysis
HOW TO GET SPEED AND DEPTH IN YOUR HOST CELL PROTEIN (HCP) ANALYSIS
In the rapidly expanding arena of biotherapeutic analysis and bioprocess development, the analysis of host cell proteins (HCP) is transitioning to a new phase. HCPs are contaminants in biotherapeutic drug preparations, often at low ppm concentration levels, and must be monitored due to stability, ef...

Knowledge Graphs for Pharma A perspective from the PhUSE Project ‘Clinical Trials Data as RDF’
KNOWLEDGE GRAPHS FOR PHARMA A PERSPECTIVE FROM THE PHUSE PROJECT ‘CLINICAL TRIALS DATA AS RDF’
This talk presents an overview of the philosophy and ongoing work of the PhUSE project "Clinical Trials Results as Resource Description Framework." The team is converting data from the CDISC Study Data Tabulation Model (SDTM) to graph data using an ontology-based approach. The wider implic...

Improving Western Blot Reproducibility: Antibodies to Automation
IMPROVING WESTERN BLOT REPRODUCIBILITY: ANTIBODIES TO AUTOMATION
Western blotting uses antibodies to identify individual proteins within a cell or tissue lysate. It is an important life sciences technique that involves many steps. When done well Western blotting delivers useful information to the researcher. Good results can, at times, be challenging.  Sourc...

Advanced Immunoprecipitation
ADVANCED IMMUNOPRECIPITATION
Identifying bona fide protein-protein interactions can be a difficult task due to the complexity of protein interactions. Immunoprecipitation of proteins can elucidate the molecular importance protein-protein interactions play in signal transduction. Join our presenters as they discuss how to identi...

Targeting Axonal Transport in Alzheimer
TARGETING AXONAL TRANSPORT IN ALZHEIMER'S DISEASE
What makes a good potential target for drug discovery? Listen in as Dr. Elizabeth Glennon, of King's College London, discusses how the disruption of axonal transports early on within Alzheimer's Disease provides excellent targets for drug discovery. How the disruption of axonal transport con...

Study Designs and Statistical Methods for Assessing the Genetic Architecture of Disease
STUDY DESIGNS AND STATISTICAL METHODS FOR ASSESSING THE GENETIC ARCHITECTURE OF DISEASE
An introduction to study designs for investigating the role of genes in disease will be provided, followed by an overview of statistical methods used to test hypotheses for each design.  Examples of several designs will be discussed, as well as accompanying methods.  Publications assessing...

Variant Assessment for Reduced Penetrance Diseases
VARIANT ASSESSMENT FOR REDUCED PENETRANCE DISEASES
Heritable disorders can often be linked back to a specific gene or genetic variant which transmits the risk of disease across generations. In most cases, the penetrance, or risk of being affected by the disease, for a pathogenic variant carrier is less than 100%. For an increasing number of disorder...

Patient-Centered Measurement: How Close Are We?
PATIENT-CENTERED MEASUREMENT: HOW CLOSE ARE WE?
When it comes to medical product discovery, development, and delivery, patients need to be front and center but how close (or far away) are we from truly having a system that routinely measures what matters to patients? A panel of industry, regulatory, and patient leaders will discuss what’s n...

Exploring the Frontiers of Data and Analytics for Precision Medicine
EXPLORING THE FRONTIERS OF DATA AND ANALYTICS FOR PRECISION MEDICINE
The frontiers of data sciences and real-world data represent promising areas of innovation and possibility for life sciences and health-care organizations, especially within precision medicine. These areas are continuously evolving, and there are questions about how to navigate this complex and rapi...

How the Internet of Things is Enabling the Medical Device Market
HOW THE INTERNET OF THINGS IS ENABLING THE MEDICAL DEVICE MARKET
Tracking inventory such as medical devices can be an arduous and manual process, especially when items are distributed in the field. Investing in an automated solution can increase workflow efficiency, save time and money, and ultimately lead to a leaner supply chain for field inventory. Utilizing R...

A Clinical Perspective on Sexually Transmitted Infections: What is the State of Play
A CLINICAL PERSPECTIVE ON SEXUALLY TRANSMITTED INFECTIONS: WHAT IS THE STATE OF PLAY
Sexually transmitted infections (STIs) continue to affect most sexually active populations across the globe, especially the traditional high-risk groups for bacterial STIs such as young people, men who have sex with men (MSM) and individuals from black and minority ethnic populations. Bacterial STIs...

Designing Reliable Medical Devices by Solving Common Interconnect Challenges
DESIGNING RELIABLE MEDICAL DEVICES BY SOLVING COMMON INTERCONNECT CHALLENGES
Individuals take for granted everyday interactions with well-designed products and devices that save both time and aggravation. Well-designed products can eliminate overall confusion for the user. Every day, more medical devices are designed for portability and at home monitoring. A major initiative...

How Multiplex-PCR Can Fit Into Diagnostic Testing Strategies for Pneumonia
HOW MULTIPLEX-PCR CAN FIT INTO DIAGNOSTIC TESTING STRATEGIES FOR PNEUMONIA
Current diagnostic methods for lower respiratory specimens typically take one to two days to identify most bacterial pathogens. During that time, clinicians must rely on guideline recommendations and clinical diagnosis to guide empiric therapy, which is not optimized based on the patient’s ind...

Assembling the eClinical Suite: Taking Advantage of the Latest Technology While Avoiding Vendor Lock-Ins
ASSEMBLING THE ECLINICAL SUITE: TAKING ADVANTAGE OF THE LATEST TECHNOLOGY WHILE AVOIDING VENDOR LOCK-INS
Not all eClinical applications are the same. For one thing, an eTMF, an EDC, and a CTMS all fulfill different functions. Perhaps more importantly, they are all built with varying degrees of complexity. The eTMF and EDC are both relatively simple applications in the IT world. Either can be introduced...

REDUCING MICROBIOLOGICAL RISK AND USING QUALITY TOOLS IN THE PHARMACEUTICAL INDUSTRY
REDUCING MICROBIOLOGICAL RISK AND USING QUALITY TOOLS IN THE PHARMACEUTICAL INDUSTRY
Manufacturing has been paid dividends for many years through the use of quality tools such as statistical process control, quality function deployment, vendor audit management, hazard analysis critical control points (HACCP), value stream analysis, and other valuation methods. In the highly regulate...

Advancing Early Cardiovascular Drug Discovery
ADVANCING EARLY CARDIOVASCULAR DRUG DISCOVERY
Innovation continues to be a primary driver of value in pharmaceutical research. However, simultaneously, research budgets are coming under ever-increasing pressure. As a consequence, pharma is moving toward a so-called open research model, one that dispenses with recurrent fixed costs in favor of a...

Advances in Aseptic Single-Use Fluid Handling and Management
ADVANCES IN ASEPTIC SINGLE-USE FLUID HANDLING AND MANAGEMENT
Single-use technology has established itself as an integral part of the biomanufacturing process helping to preserve space, increase flexibility, and save money. Thoughtful design for the handling and transfer of sterile liquids is a key consideration when designing single use systems, and advances ...

Therapeutic Antibody Discovery by Mammalian Display
THERAPEUTIC ANTIBODY DISCOVERY BY MAMMALIAN DISPLAY
Using directed integration of antibody genes by CRISPR/Cas9 and TALENs, the construction of large libraries in mammalian cells containing a single antibody gene/cell has been achieved. This accomplishment has enabled the construction of libraries containing millions of monoclonal, stable, cell lines...

Cancer Gene Expression Targets Validated Using Novel Histopathology Tools
CANCER GENE EXPRESSION TARGETS VALIDATED USING NOVEL HISTOPATHOLOGY TOOLS
When assessing a potential biological therapeutic candidate, several histopathological technologies are typically employed. This ensures the target expression is validated in both normal and diseased tissues before proceeding with pre-clinical studies. Protein B is a transmembrane glycoprotein that ...

Antibodies and Antibody-Drug Conjugate Higher Order Structures Revealed
ANTIBODIES AND ANTIBODY-DRUG CONJUGATE HIGHER ORDER STRUCTURES REVEALED
Recently investigators have begun to harness new technology such as microfluidic modulation spectroscopy (MMS) to reveal protein structural changes, as a solid understanding of structure and function is extremely important to the effectiveness of biotherapeutic drugs and scientist today are challeng...

How a Top-5 Pharma Doubled the Speed of Cell Line Development
HOW A TOP-5 PHARMA DOUBLED THE SPEED OF CELL LINE DEVELOPMENT
Single cell cloning (SCC) is a critical and high-value process for an increasing number of applications including cell engineering; stable cell lines for therapeutic mAbs and biosimilars; vector production for gene therapy; and many more. During this webinar, Tom Kelly from Janssen (part of Johnson ...

Tufts Research: Strategies from Data Management Leaders to Speed Clinical Trials
TUFTS RESEARCH: STRATEGIES FROM DATA MANAGEMENT LEADERS TO SPEED CLINICAL TRIALS
Learn how top pharma and CROs plan to speed database build and data collection, as well as their top challenges and future priorities. Join this webinar to gain insights into Taking an agile approach to database buildReducing user acceptance testing (UAT) timelines with a risk-based approach. Drivin...

Triple Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
TRIPLE NEGATIVE BREAST CANCER RISK GENES IDENTIFIED BY MULTIGENE HEREDITARY CANCER PANEL TESTING
In this webinar, Dr. Couch will present results from a recent study of multigene hereditary cancer panel testing in >10,000 women with triple-negative breast cancer (TNBC), focusing on the prevalence of cancer gene mutations among TNBC cases along with gene-specific associations with TNBC among C...

Advances in Family History & Clinical Data Management Tools and Their Impact on Precision Medicine
ADVANCES IN FAMILY HISTORY & CLINICAL DATA MANAGEMENT TOOLS AND THEIR IMPACT ON PRECISION MEDICINE
During this one-hour live webinar, attendees will listen to Jamie L’Heureux, CEO of Progeny Genetics, discuss the advances in electronic family history collection and the benefits of pairing this with a strong clinical data management platform to maximize user efficiency and improve patient ma...

Evolution in the Manufacturing of Cellular Therapies- lessons learned and current solutions
EVOLUTION IN THE MANUFACTURING OF CELLULAR THERAPIES- LESSONS LEARNED AND CURRENT SOLUTIONS
Immunotherapy is a powerful treatment that harnesses the body’s immune system in the fight against cancer. With optimized cell therapy, the result is an expanded population of T cells primed to recognize and eradicate malignant tumor cells that would otherwise escape immune detection. The webi...

Novel Approaches to Quantitative Metabolomics
NOVEL APPROACHES TO QUANTITATIVE METABOLOMICS
A frequently challenging field, metabolomics is often considered the most direct approach to making quantitative measurements that can be related to the physiological state of an organism. In this exclusive online symposium, you will discover new and novel approaches to quantitative metabolomics as ...

Using Micro-CT Imaging for the Phenotyping and Analysis of Bone Architecture
USING MICRO-CT IMAGING FOR THE PHENOTYPING AND ANALYSIS OF BONE ARCHITECTURE
Micro-computed tomography (micro-CT) offers significant advantages over other X-ray imaging techniques in the field of bone research. Its high-level X-ray absorption enables good contrast and the ability to observe bone in very fine detail, not only in bone density studies but also those examining t...

Expanding Biobanking Size and Scope to Advance Big Data Discovery
EXPANDING BIOBANKING SIZE AND SCOPE TO ADVANCE BIG DATA DISCOVERY
Currently, the Cleveland Clinic Biorepository is an assembly of several biobanks together with the Lerner Research Institute. Excel spreadsheets track almost everything – and there are no universal LIS, SOPs, universal, centralized freezer monitoring, or means to electronically track patient t...

ADVANCES AND CHALLENGES IN VACCINE DEVELOPMENT AND MANUFACTURE
ADVANCES AND CHALLENGES IN VACCINE DEVELOPMENT AND MANUFACTURE
This webinar reviews the constraints and complexities of vaccine product development and manufacture. The evolution of bioprocess and analytics innovation and technologies to overcome these challenges are discussed. The strategy and leveraging of innovation and technology for rapid product developme...

Risk stratification of the apparently healthy population with ARCHITECT STAT High Sensitive Troponin-I
RISK STRATIFICATION OF THE APPARENTLY HEALTHY POPULATION WITH ARCHITECT STAT HIGH SENSITIVE TROPONIN-I
In this webinar, you will hear about a recently CE marked application for ARCHITECT STAT High Sensitive Troponin I, that aids in providing greater accuracy for estimation of risk for future cardiac events in apparently healthy people, when used in conjunction with clinical and diagnostics findings. ...

Medicare Provider Agreement Assignment Following Change of Ownership: Evaluating Automatic Assignment vs. Rejection
MEDICARE PROVIDER AGREEMENT ASSIGNMENT FOLLOWING CHANGE OF OWNERSHIP: EVALUATING AUTOMATIC ASSIGNMENT VS. REJECTION
This CLE webinar will guide healthcare counsel on navigating a change of ownership (CHOW) in healthcare transactions when Medicare provider agreements are involved. The panel will discuss the factors to consider when determining whether to accept or reject the assignment of the provider agreement an...

CRISPR-created Animal Models: The Technical Lowdown
CRISPR-CREATED ANIMAL MODELS: THE TECHNICAL LOWDOWN
Creating reproducible animal models for long-term studies can often be problematic due to the complexity of the genetic modification(s) required. Suboptimal design strategies compound the challenges by generating undesired genotypic or phenotypic results. CRISPR-Cas9 or zinc-finger nuclease (ZFN)-ba...

Cell Signaling and Metabolism: Bridging a Gap in Cancer Therapies
CELL SIGNALING AND METABOLISM: BRIDGING A GAP IN CANCER THERAPIES
That cancer cells display an altered metabolism has been known for almost a century, but the cell-signaling mechanisms responsible for this phenomenon are just beginning to be understood, with some drugs targeting key regulators of both cell metabolism and tumor progression. The repurposing of old d...

The Brain-Microbiome Axis: Links Between Neurological Disease and Microbiota
THE BRAIN-MICROBIOME AXIS: LINKS BETWEEN NEUROLOGICAL DISEASE AND MICROBIOTA
The human microbiome consists of trillions of commensal microbes. These include bacteria, fungi, and viruses, which naturally reside within the human body and have been documented to affect epigenetic mechanisms, metabolic activity, and immune system function. Researchers are now focusing on how mic...

Stem Cells: Opportunities, Hurdles, and Promises
STEM CELLS: OPPORTUNITIES, HURDLES, AND PROMISES
Since Sir. Martin Evans’ 1981 identification of embryonic stem cells in mice, stem cells have been at the center of the drive to revolutionize medicine and the drug discovery process. In 1998, human embryonic stem cells were grown in a lab, and the field was further boosted in 2006 with the pi...

CURRENT USP PERSPECTIVES ON A RAPID STERILITY TEST
CURRENT USP PERSPECTIVES ON A RAPID STERILITY TEST
The current growth-based Sterility Tests with at least 14-days incubation is not suitable for short-lived products. An expert panel was formed under the USP General Chapters– Microbiology Expert Committee to provide recommendations on user requirements specifications and candidate technologies...

Botanical Identification - Authentication vs Adulteration
BOTANICAL IDENTIFICATION - AUTHENTICATION VS ADULTERATION
This webinar addresses the complex methods of botanical identification of natural nutraceutical and functional foods, and how adulteration of substances is discovered. It’s an exciting journey through the realm of chemical marker compounds, ratio comparison, and the latest in quality assurance...

The 3 R’s of cancer therapy: Response, Resistance, and Relapse
THE 3 R’S OF CANCER THERAPY: RESPONSE, RESISTANCE, AND RELAPSE
The 3 R’s: Response, Resistance, and Relapse Simplistic View of Cancer: a Monolith Patterns of response and resistance. Tumors Have Many Clones. Not One 4 identical mutations shared by one region of the chest wall and perinephric metastasis Darwinian Selection and Branched Evolution Mutation V...

Recent advances in diagnostics and treatments - from small molecules to cellular therapies
RECENT ADVANCES IN DIAGNOSTICS AND TREATMENTS - FROM SMALL MOLECULES TO CELLULAR THERAPIES
The majority of clinically approved medicines are synthetic small molecules that modulate target activity, usually by inhibiting the function of a single protein. A fraction of these small molecule medicines exert their therapeutic effect by activating protein targets and disrupting protein-protein ...

IS INDIA ANYWHERE CLOSER TO IMPLEMENTING CONTINUOUS BIOPROCESSING
IS INDIA ANYWHERE CLOSER TO IMPLEMENTING CONTINUOUS BIOPROCESSING
Continuous processing has been widely employed in many biological manufacturing processes. In recent years it gained the momentum in the field of Biosimilar manufacturing due to an ever-increasing pressure for reduction in manufacturing costs. Potentially, the continuous processing offers Lower Cost...

MIXED MODE CHROMATOGRAPHY IN PURIFYING BIOLOGICS – OVERVIEW
MIXED MODE CHROMATOGRAPHY IN PURIFYING BIOLOGICS – OVERVIEW
The market for therapeutic proteins such as monoclonal antibodies (mAbs), growth hormones, other recombinant therapeutic proteins has grown tremendously in the last two decade. To compete in the biopharmaceutical market, we should identify, develop the high product producing clone and find the best ...

EVOLVE MANUFACTURING PROCESSES BY IMPLEMENTING DISRUPTIVE TECHNOLOGIES
EVOLVE MANUFACTURING PROCESSES BY IMPLEMENTING DISRUPTIVE TECHNOLOGIES
The desire for innovative technology that can eventually cause disruptive changes remains high in the biotech pharmaceutical industry. The road between pursuing and developing that technology to genuine implementing is not a smooth ride. In this webinar, the presenter identifies key challenges of im...

Recent Changes to Drug Approvals in China: Regulatory Consultation, IND Submission and Acceptance of Foreign Data in NDA
RECENT CHANGES TO DRUG APPROVALS IN CHINA: REGULATORY CONSULTATION, IND SUBMISSION AND ACCEPTANCE OF FOREIGN DATA IN NDA
Historically, the review and approval of a Chinese investigational new drug (IND) have taken a year or even longer to complete, and new drug application (NDA) approval for a new drug lagged behind Western countries by four or five years. Recently, the National Medical Products Administration announc...

Simplifying Clinical Data Flow from EDC to SDTM
SIMPLIFYING CLINICAL DATA FLOW FROM EDC TO SDTM
Recent trends in clinical trials – including the increasing availability of clinical, operational and real-world data streams – offer the opportunity to gain better insight over clinical R&D as never before, but poses interesting challenges with data aggregation, harmonization, and c...

Endodontic applications of microcomputed tomography for studying root canals
ENDODONTIC APPLICATIONS OF MICROCOMPUTED TOMOGRAPHY FOR STUDYING ROOT CANALS
Endodontics is a specialty within the field of dentistry concerned with the morphology, physiology, and pathology of the human dental pulp and periradicular tissues. Recent technological advancements have led to several new methods for visualizing the anatomy of the human teeth, but, over the last d...

Molecular Testing Guideline for Selection of Lung Cancer Patients
MOLECULAR TESTING GUIDELINE FOR SELECTION OF LUNG CANCER PATIENTS
The advent of targeted therapies based on predictive biomarkers has dramatically altered the role of the molecular pathologist in lung cancer patient care. This webinar reviews the new recommendations published in the revised 2018 CAP/IASLC/AMP lung cancer predictive biomarker guidelines (Lindeman e...

Genetics and Genomics 2018
GENETICS AND GENOMICS 2018
Our 6th Annual Genetics and Genomics Virtual Conference are now available On Demand! As the foundation of life, genetics provides a base for other sciences to grow from. This free on-demand event will cover the most recent and exciting advances in genetics research. Participants of the Genetics 2018...

Drug Development – The 6 Most Critical Reasons Why Drugs are Delayed When Planning and Conducting CTA/IND Enabling Studies
DRUG DEVELOPMENT – THE 6 MOST CRITICAL REASONS WHY DRUGS ARE DELAYED WHEN PLANNING AND CONDUCTING CTA/IND ENABLING STUDIES
Bringing a drug from discovery to market is an expensive and time-consuming business. Every drug that fails comes with a cost which could be both reputational and financial. Keeping your development program on track is therefore critical to success. In this webinar, our featured speaker will explore...

Telehealth drug prescribing & the opioid crisis: What every doctor needs to know
TELEHEALTH DRUG PRESCRIBING & THE OPIOID CRISIS: WHAT EVERY DOCTOR NEEDS TO KNOW
Why is there a good chance you're illegally prescribing medication over telehealth? How are telehealth prescribing rules changing with the opioid crisis? Is an in-person exam necessary for prescribing medication online? How does telehealth drug prescribing work across state lines or internationa...

Navigating Data Management Challenges in Every Phase of the Drug Discovery Life Cycle
NAVIGATING DATA MANAGEMENT CHALLENGES IN EVERY PHASE OF THE DRUG DISCOVERY LIFE CYCLE
How do you ensure a smooth and efficient progression throughout your product’s lifecycle? From Discovery to Post Marketing, each phase along the way comes with a unique set of data management challenges. In this webinar, we’ll introduce you to laboratory information management systems (L...

Advanced optical hematology technology for elevated analytical performance
ADVANCED OPTICAL HEMATOLOGY TECHNOLOGY FOR ELEVATED ANALYTICAL PERFORMANCE
Today, hematology analyzers can collect vast amounts of data about cell characteristics, that subsequently improve disease detection. Advanced systems can perform a complete blood count (CBC) and classify multiple cell types, including more than the normal five subclasses of mature white blood cells...

Current Controversies in the Epidemiology, Diagnosis, and Management of Vaginal Infections
CURRENT CONTROVERSIES IN THE EPIDEMIOLOGY, DIAGNOSIS, AND MANAGEMENT OF VAGINAL INFECTIONS
Vaginal infections are a source of considerable morbidity among women. It is estimated that there are more than 10 million office visits per year due to vaginal infections. The three main causes of infectious vaginitis are vulvovaginal candidiasis (VVC), trichomoniasis, and bacterial vaginosis (BV)....

Transforming Clinical Trial Operations: The Next Big Step
TRANSFORMING CLINICAL TRIAL OPERATIONS: THE NEXT BIG STEP
Research shows that today’s clinical technology landscape is siloed, prompting an industrywide move to unify clinical trial systems and streamline end-to-end processes for better visibility and improved study execution. In a recent industry survey, 99% of respondents reported the need to unify...

Oncology Drug Access Navigators - Benefits to Patients & Health Care Teams
ONCOLOGY DRUG ACCESS NAVIGATORS - BENEFITS TO PATIENTS & HEALTH CARE TEAMS
Alan Birch discussed the role of an Oncology Drug Access Navigator as well as how the role fits into the healthcare team and what they help patients with. He gave a brief overview and history of the role as well as discussing challenges faced by patients and how National Pharmacare may impact it all...

Drug Discovery 2018
DRUG DISCOVERY 2018
Despite the rapid pace of scientific advances that garner a better understanding of a myriad of diseases on their molecular level, modern drug discovery is a long, complex process. As to be expected, the course of action for researching and developing new medicines is growing in difficulty and lengt...

Neuroscience 2018
NEUROSCIENCE 2018
Our  6th Annual world-renowned Neuroscience virtual conference is now available On Demand! Neuroscience 2018 aims to explore the mechanisms of neural function from the molecular to the network level in health and disease. World-renowned experts and thought leaders discussed the dynamics of brai...

Solving Medical Technology Product Development Issues
SOLVING MEDICAL TECHNOLOGY PRODUCT DEVELOPMENT ISSUES
There is an increasing number of emerging medical technologies (MedTech) which are having a significant effect on the medical equipment and medical device industries. The main principles that come into play when applying these new medical technologies are design for manufacturability, thinking ahead...

Recent Technological Advancements in Medical Communication
RECENT TECHNOLOGICAL ADVANCEMENTS IN MEDICAL COMMUNICATION
Join this webinar for a discussion of the most common medical communications business challenges and potential solutions. This event will also feature a live demonstration of how patient-centric medical communications technology can be leveraged to streamline and optimize medical inquiry fulfillment...

Clinical Supply Planning Optimization
CLINICAL SUPPLY PLANNING OPTIMIZATION
This webinar provides a comprehensive overview of the current supply planning landscape, identifies gaps which are inhibiting supply professionals from optimizing their supply chains and delves into solutions for driving efficiencies from a people, process and technology perspective. Also to be disc...

How to Solve Big Challenges in Small Biotechs Using Big Data Analytics
HOW TO SOLVE BIG CHALLENGES IN SMALL BIOTECHS USING BIG DATA ANALYTICS
Small biotechs are the engine of scientific innovations in the biopharmaceutical industry. However, they are saddled with many of the challenges facing big companies such as data silos and challenges to quick access to information critical to managing their clinical trials. This is manifested by the...

3D Organ-on-a-chip Applications Using the AIM Biotech Chip
3D ORGAN-ON-A-CHIP APPLICATIONS USING THE AIM BIOTECH CHIP
In the vitro 3D cell, culture models have emerged as a bridge between conventional 2D cell culture models and the complex & expensive in vivo animal models. By analyzing and comparing the biological behavior of tissues embedded in 3-dimensional hydrogels, results are significantly different from...

Intellectual Property in biotech: from bioprinting to bedside
INTELLECTUAL PROPERTY IN BIOTECH: FROM BIOPRINTING TO BEDSIDE
TeVido BioDevices uses the innovative process of 3D bioprinting living human cells for use as implants or grafts for use in reconstructive surgery and wound care, for example in post-surgery care for cancer patients. TeVido uses a simple yet sophisticated approach to produce living tissue products -...

Patient-Centric IRT Management for Compassionate Use Studies
PATIENT-CENTRIC IRT MANAGEMENT FOR COMPASSIONATE USE STUDIES
When developing lifesaving medications for patients is at your core, it is essential to streamline the processes of managing the critical clinical supplies and trial data through advanced technology. The pooled clinical supply approach, when coupled with a comprehensive control system, offers unique...

Harmonising drug-target binding data analytics on a single platform
HARMONISING DRUG-TARGET BINDING DATA ANALYTICS ON A SINGLE PLATFORM
In early-stage medicines research, measuring in vitro drug-target interaction characteristics is a critical path activity in selecting therapeutic candidates for progression into pre-clinical models. Technologies and instrumentation used in this space are numerous. Bespoke instrument-specific data a...

High throughput screening for deep mining of antibody repertoires
HIGH THROUGHPUT SCREENING FOR DEEP MINING OF ANTIBODY REPERTOIRES
Antibodies are the key drivers of new drug development based on biologics rather than small molecules. Multiple blockbuster drugs have emerged in this area, many more are in the pipeline. In this webinar, Stefan Moese talks about the implementation of a high throughput screening approach for mining ...

Analytical Chemistry 2018
ANALYTICAL CHEMISTRY 2018
The field of analytical chemistry is focused on advancements in experimental design, chemometrics, and the creation of new analytical instrumentation. Analytical chemistry has broad applications into forensics, environmental testing, pharmacological developments, material science, and engineering. J...

Fit-for-Future Pharmacovigilance Sourcing Strategies
FIT-FOR-FUTURE PHARMACOVIGILANCE SOURCING STRATEGIES
The challenges and demands of pharmacovigilance in today’s climate has shifted significantly. How do we determine what should and can be sourced differently compared to our traditional models? Offshore-outsourced blended models are becoming increasingly popular. Join this webinar for a discuss...

Nuclear Imaging of CNS Diseases in Rodent Models
NUCLEAR IMAGING OF CNS DISEASES IN RODENT MODELS
Nuclear imaging provides translational and noninvasive in vivo methodology to reliably quantify pathological changes during disease progression and allows evaluation of therapeutic effects of existing or novel drugs against the disease. This webinar showcases new developments of CNS Discovery Servic...

Inhalation Drug Delivery: Considerations for Toxicology and Pharmacology Research
INHALATION DRUG DELIVERY: CONSIDERATIONS FOR TOXICOLOGY AND PHARMACOLOGY RESEARCH
Drug delivery to the lungs in both the clinical and non-clinical setting is a unique combination of formulation, the delivery device and the system/model that the drug is being delivered to. Throughout different stages of drug development, the requirements for inhalation drug delivery change and the...

Getting the Most Out of Interactive Response Technology in Clinical Trial Supply
GETTING THE MOST OUT OF INTERACTIVE RESPONSE TECHNOLOGY IN CLINICAL TRIAL SUPPLY
Increasingly complex, international clinical trials demand a smart, comprehensively planned approach. With the correct interactive response technology (IRT) system in place, you have a powerful tool for accelerating your product’s progress to launch.  While IRT manages patient interaction...

Pediatric Cancer Genomics: Accessing Data, Tools and Visualizations in St. Jude Cloud
PEDIATRIC CANCER GENOMICS: ACCESSING DATA, TOOLS AND VISUALIZATIONS IN ST. JUDE CLOUD
Next-generation genomic sequencing is transforming what is known about pediatric cancer and how we treat patients. But even with new technologies, challenges remain. In the past, the sheer size of genomics data has made sharing across the global scientific community a challenge. St. Jude Cloud is a ...

Better Target Validation for Drug Discovery with CRISPR/Cas9
BETTER TARGET VALIDATION FOR DRUG DISCOVERY WITH CRISPR/CAS9
Better target validation is a key driver of better productivity in drug discovery. The RNA-guided nucleases, exemplified by Cas9, represent a powerful new approach to understanding gene function and, in principle, to reveal the next generation of therapeutic targets. But how well does this technolog...

Transforming translational research: CANscript–A better predictive model for oncology
TRANSFORMING TRANSLATIONAL RESEARCH: CANSCRIPT–A BETTER PREDICTIVE MODEL FOR ONCOLOGY
In this webinar, speaker Mark Paris, Ph.D. discussed a recent study evaluating a cohort of HNSCC patient tumors treated with anti-PD1 using CANscript™. He also is reviewed the results of this study as a means of investigating predictors of clinical response and identifying mechanisms of resist...

Advanced process development using automated micro bioreactors shortens timeline
ADVANCED PROCESS DEVELOPMENT USING AUTOMATED MICRO BIOREACTORS SHORTENS TIMELINE
Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmac...

Starting a Third Party Analytical Laboratory in the Cannabis Industry
STARTING A THIRD PARTY ANALYTICAL LABORATORY IN THE CANNABIS INDUSTRY
In this webinar, we will explore the challenges and opportunities of starting a third-party testing laboratory in the cannabis industry. Seth Wong, a 15-year seasoned laboratory executive, will walk us through his experience starting a new ISO/IEC 17025 analytical lab on the University of Colorado A...

Proving the Strategic Value of Patients
PROVING THE STRATEGIC VALUE OF PATIENTS
Patient insights aren’t just a ‘nice to have’: they are essential to understanding the space where Pharma’s drugs ‘live’. On the 10th October, Cello Health Insight in association with PMGroup will look at the value of three areas of patient research that provide t...

The mast cell receptor MrgX2 and drug-induced anaphylaxis
THE MAST CELL RECEPTOR MRGX2 AND DRUG-INDUCED ANAPHYLAXIS
Activation of MrgX2, a GPCR expressed on mast cells, leads to degranulation and histamine release. MrgX2 binds promiscuously to basic peptides and small molecules, resulting in acute histamine-like adverse drug reactions, both in man and in mammalian species used in drug toxicology. The goal of this...

Realising the biotech promise: addressing the path to market
REALISING THE BIOTECH PROMISE: ADDRESSING THE PATH TO MARKET
Now more than ever before, Biotech is the engine for innovation in medicine, finding, creating and delivering ground-breaking treatments to patients. The journey from molecule discovery and development through valuation, funding, regulatory and commercialization can be a long and complex road to tra...

Identify and Quantify Individual Host Cell Proteins
IDENTIFY AND QUANTIFY INDIVIDUAL HOST CELL PROTEINS
ELISA is the golden standard for HCP analysis but has some drawbacks. It only provides a single number (ng HCP/mg drug substance) and no information about the specific HCP’s. Here we present an HCP analysis method based on a SWATH LC-MS that provides reproducible identification and absolute qu...

Association of Biotin Ingestion with Performance of Hormone and Nonhormone Assays in Healthy Adults
ASSOCIATION OF BIOTIN INGESTION WITH PERFORMANCE OF HORMONE AND NONHORMONE ASSAYS IN HEALTHY ADULTS
High dose of biotin may cause interference with many routine clinical immunoassays and inaccurate results of some of the tests such as cardiac troponin have serious clinical complications. There is an increasing trend of high dose biotin supplement use in the US population, although the exact preval...

Good culture for your cells - Best practices for preventing contamination
GOOD CULTURE FOR YOUR CELLS - BEST PRACTICES FOR PREVENTING CONTAMINATION
Are ethanol and antibiotics the best measures to prevent microbial contamination? Contamination is an everyday challenge in cell culture labs. Undetected or ignored contamination endanger the reliability and reproducibility of experimental data.  Get to know the most effective methods to detect...

The Future of Marketing in Life Sciences: Is your function fit for purpose?
THE FUTURE OF MARKETING IN LIFE SCIENCES: IS YOUR FUNCTION FIT FOR PURPOSE?
The healthcare landscape is rapidly changing as it responds to a multitude of well-known issues. Coupled with emerging digital technologies, these drivers are shaping the industry, moving it towards a more sophisticated, outcomes-driven model that demands a new approach. The new world emerging is on...

CRISPR 2018
CRISPR 2018
With continued adoption and integration in research labs, CRISPR gene editing has gained importance both as a research tool in drug discovery, screening, and therapeutic development. This inaugural event will bring together thought leaders from academia, trained researcher from clinical laboratories...

Improving hepatocyte activity, pooling and lab efficiency
IMPROVING HEPATOCYTE ACTIVITY, POOLING AND LAB EFFICIENCY
CryostaX® hepatocytes are created using a patented process that produces unique single-donor cell pellets. This format allows for distinct benefits to hepatocyte performance, efficiency in the lab, and test system design, precipitating the potential discontinuation of cryopreserved hepatocytes p...

Quantify Intact Virus Particles More Precisely And Faster Than qPCR
QUANTIFY INTACT VIRUS PARTICLES MORE PRECISELY AND FASTER THAN QPCR
An analytical quality by design (AQbD) approach was embraced for the development of a capillary zone electrophoresis (CZE) method for the quantification of intact virus particles. With CE, the intact adenovirus particles were separated from sample matrix components such as cell debris, residual cell...

Laboratory Animal Sciences 2018
LABORATORY ANIMAL SCIENCES 2018
The 7th annual Laboratory Animal Sciences (LAS) virtual conference is now available on-demand! The LAS Planning Committee, led by Dr. Szczepan Baran, Global Head of Animal Welfare and Compliance Training at Novartis Pharmaceuticals, and composed of more than 20 world-renowned experts, will plan and ...

Using AI and IoT to Accelerate Research
USING AI AND IOT TO ACCELERATE RESEARCH
A serial entrepreneur in sensors, IoT, medical devices, and wearables, Sridhar is founded Elemental Machines with the mission to build products to help science-based companies decipher and understand physical processes from R&D to manufacturing. Previously, Sridhar was a founder of Misfit, maker...

Skin toxicity mechanisms associated with mGluR5 negative allosteric modulators
SKIN TOXICITY MECHANISMS ASSOCIATED WITH MGLUR5 NEGATIVE ALLOSTERIC MODULATORS
Cutaneous reactions represent one of the most common adverse drug effects observed in clinical trials leading to substantial compound attrition. In this webinar, Falgun Shah discussed three negative allosteric modulators of metabotropic glutamate receptors, developed by Pfizer, which recently failed...

Improving Intact Antibody and Plasma Glycoprotein Analysis with Native MS and Parsimonious Charge Deconvolution
IMPROVING INTACT ANTIBODY AND PLASMA GLYCOPROTEIN ANALYSIS WITH NATIVE MS AND PARSIMONIOUS CHARGE DECONVOLUTION
Recent developments in mass spectrometry technology have enabled the analysis of intact native glycoproteins and protein complexes using Orbitrap mass analyzers with extended mass ranges  (EMR). High sensitivity and resolution enable the profiling of critical quality attributes and biosimilarit...

Defects in potassium channels contribute to reduced immune surveillance in cancers
DEFECTS IN POTASSIUM CHANNELS CONTRIBUTE TO REDUCED IMMUNE SURVEILLANCE IN CANCERS
Harnessing the immune system has emerged as a powerful therapeutic strategy in oncology. However, the limited ability of cytotoxic CD8+ T cells to infiltrate solid tumors presents a major roadblock to developing effective immunotherapy. Cytotoxic CD8+ T cells, in fact, have to infiltrate solid tumor...

In vitro phenotypic assays for Parkinson’s disease
IN VITRO PHENOTYPIC ASSAYS FOR PARKINSON’S DISEASE
The discovery and validation of novel targets are essential to fuel a healthy drug pipeline, and in vitro phenotypic assays are instrumental for delivering valid targets and promising lead molecules. View this webinar to learn more about our in vitro assay capabilities performed in clinically releva...

Advanced process development using automated micro bioreactors shortens the timeline
ADVANCED PROCESS DEVELOPMENT USING AUTOMATED MICRO BIOREACTORS SHORTENS THE TIMELINE
In the last eight years, the ambr platform has developed into a significant component of the toolset used by the biopharmaceutical industry for a wide range of upstream activities. The small-scale, high throughput nature of the systems coupled with the associated software functionality enables many ...

Drug Antibody Ratio (ADC) Calculations Made Easy by CE
DRUG ANTIBODY RATIO (ADC) CALCULATIONS MADE EASY BY CE
Antibody drug conjugates are gaining interest as new therapeutic drug targets in the BioPharma Industry. Recent developments in separations technology are enabling scientists to easily calculate antibody drug payloads of both cysteine and lysine conjugates of thermally stressed samples.

Phenotypic assays for CNS disease drug discovery
PHENOTYPIC ASSAYS FOR CNS DISEASE DRUG DISCOVERY
Central nervous system (CNS) disorders constitute a growing unmet medical need, with increasing prevalence of aging-related diseases (Alzheimer’s and Parkinson’s). While classical approaches in cell lines and primary neurons are valuable, (patient-derived) stem cell-based neuronal model ...

High-throughput Single Cell RNA-seq from Flow-Sorted Cells Using a Novel Miniaturized CEL-seq2 Protocol
HIGH-THROUGHPUT SINGLE CELL RNA-SEQ FROM FLOW-SORTED CELLS USING A NOVEL MINIATURIZED CEL-SEQ2 PROTOCOL
Plate-based scRNA-seq approaches are advantageous for the in-depth analysis of rare cell types and subpopulations selected by cell surface markers. This webinar will introduce a high-throughput process for generating sequencing libraries from single cells sorted into 384-well plates. Due to the redu...

Using open science to develop Pediatric Cancer Drugs
USING OPEN SCIENCE TO DEVELOP PEDIATRIC CANCER DRUGS
Childhood brain tumors are genetically distinct from adult cancers and are not a focus area for drug development. M4K Pharma is pioneering a novel open science business model to address these unprecedented “high risk” targets for a fraction of the usual cost. In this webinar, the speaker...

Art Therapy Interventions for Traumatized Children
ART THERAPY INTERVENTIONS FOR TRAUMATIZED CHILDREN
Most clinicians who work with children use art as a way to connect with their young clients, and there has been an increase in referrals for services for children who have experienced significant trauma. This topic will provide clinicians with an introduction to art therapy history and theory, a dis...

Answer the challenges of CDS Data integrity - Sterling Pharma Solutions Ltd
ANSWER THE CHALLENGES OF CDS DATA INTEGRITY - STERLING PHARMA SOLUTIONS LTD
Data integrity continues to be a hot topic for the regulatory agencies in the pharmaceutical industry. In 2012, Sterling Pharma Solutions, embarked on a mission to replace their existing chromatography data systems (CDS). It was important to have one system for the entire company spanning both labor...

Drug-Antibody Ratio (ADC) Calculations Made Easy by CE
DRUG-ANTIBODY RATIO (ADC) CALCULATIONS MADE EASY BY CE
Antibody-drug conjugates are gaining interest as new therapeutic drug targets in the BioPharma Industry. Recent developments in separations technology are enabling scientists to easily calculate antibody drug payloads of both cysteine and lysine conjugates of thermally stressed samples.

Early disease detection performing NMR - Understanding how a better analysis of metabolites in serum and urine can help
EARLY DISEASE DETECTION PERFORMING NMR - UNDERSTANDING HOW A BETTER ANALYSIS OF METABOLITES IN SERUM AND URINE CAN HELP
Quantification in body fluids like plasma/serum and urine is valuable because it provides information on endogenous compounds produced in the body as well as capturing drugs and their metabolites, in addition, lifestyle-based molecules can be recognized, be it from nutritional habits or physical act...

Biomarker endpoints for Parkinson’s disease
BIOMARKER ENDPOINTS FOR PARKINSON’S DISEASE
Therapeutic approaches for Parkinson’s disease are either focused on disease modification (a-synuclein or MPTP models) or symptom management (haloperidol or 6-OHDA models). Our scientists have validated available PD models for changes in fine motor skills, L-dopa-induced dyskinesias, drug-indu...

3D Cell Cultures and Tissue Clearing
3D CELL CULTURES AND TISSUE CLEARING
With the advent of cost-effective culturing approaches, 3D cell culture models (3D-CCMs) have been rapidly adopted for drug discovery since they provide a more physiologically relevant micro-environment; showing improved predictive utility for assessing drug efficacy and/or toxicity when compared to...

Streamlining drug discovery assays for cancer and cardiovascular disease
STREAMLINING DRUG DISCOVERY ASSAYS FOR CANCER AND CARDIOVASCULAR DISEASE
Declining R&D productivity is a key challenge in the pharmaceutical industry today. To increase the success rate of candidate drugs entering the clinical phase, companies must address the early stages of drug discovery. In lead optimization, target-based assays are still the most affordable mean...

Impact of Vicarious Traumatization on Healthcare Workers
IMPACT OF VICARIOUS TRAUMATIZATION ON HEALTHCARE WORKERS
There is a growing healthcare crisis in the ranks of healthcare providers. High demand care areas, higher patient acuities, fewer resources and more work demands deplete care providers of their personal reserves. Unidentified, this problem can manifest as joylessness, hostility, and aggression among...

From Slow Analytics Adoption to Data-Driven Sales Success
FROM SLOW ANALYTICS ADOPTION TO DATA-DRIVEN SALES SUCCESS
What’s the secret to getting widespread analytics adoption across your organization? Using a thoughtful, modern approach. Biotech giant Sanofi Genzyme influenced senior executives, managers, and field sales teams to adopt Qlik® solutions. Watch our Customer Spotlight Webinar to hear their ...

Using Reference Standards to Validate your NGS Oncology Workflow
USING REFERENCE STANDARDS TO VALIDATE YOUR NGS ONCOLOGY WORKFLOW
We are currently at an exciting precipice in clinical oncology management, where an increased rate of biomarker identification is driving the development of new targeted therapies, coupled with advances in sequencing technology capability. In the latest version release of COSMIC (v85) there are now ...

Large-Scale Brain Mapping for Reverse Engineering Brain Function
LARGE-SCALE BRAIN MAPPING FOR REVERSE ENGINEERING BRAIN FUNCTION
The Kasthuri lab is pioneering new techniques for large volume reconstructions of the fine structure of the nervous system – ‘connectomics’. In this webinar, Dr. Kasthuri will describe these developments including large volume automated electron microscopy for mapping neuronal conn...

Tackle biologics QC with Hound and Bouncer
TACKLE BIOLOGICS QC WITH HOUND AND BOUNCER
Particles muck up the quality of a drug and can shut down its production. Hound is the only tool out there that analyzes particles by size and shape then forensically identifies them by their chemical and elemental fingerprints. In minutes, you can pinpoint the culprit, track it back to the source, ...

Step up your biologics stability screening with Hunky
STEP UP YOUR BIOLOGICS STABILITY SCREENING WITH HUNKY
Many methods for studying protein stability and aggregation are qualitative, which can cause uncertainty when moving drug candidates and formulations forward. In contrast, Hunky gives you the Gibbs free energy (ΔG) of a protein, which is a powerful and quantitative indicator of the amount of u...

Advancing precision immunotherapy through next-generation sequencing of T cell receptors: Part I
ADVANCING PRECISION IMMUNOTHERAPY THROUGH NEXT-GENERATION SEQUENCING OF T CELL RECEPTORS: PART I
This webinar will review recent advancements in the application of next-generation sequencing of T cell receptor beta (TCRB) chain repertoires towards predictive and mechanistic biomarker discovery for cancer immunotherapy. Dr. Looney will focus on immunotherapy biomarker applications of a long-ampl...

Precision Medicine 2018
PRECISION MEDICINE 2018
Our 3rd Annual Precision Medicine Virtual Conference is now available On Demand! Precision Medicine 2018 will continue the dialogue and provide updates on new efforts in drug discoveries, developments in FDA regulatory structures, and the integration of genetics on disease progression. Precision Med...

CRISPR for Disease Detection and the Future of Accessible Healthcare
CRISPR FOR DISEASE DETECTION AND THE FUTURE OF ACCESSIBLE HEALTHCARE
This webinar explores the technology behind Mammoth Biosciences’ newly announced CRISPR-powered diagnostics platform, giving insight to CRISPR and how it works for disease detection. In this webinar, Ashley will first give an explanation of what CRISPR does and how it’s been used up unti...

Exon-level array: Bridging the gap between chromosomal microarray and next-gen sequencing
EXON-LEVEL ARRAY: BRIDGING THE GAP BETWEEN CHROMOSOMAL MICROARRAY AND NEXT-GEN SEQUENCING
Current exon-level arrays and NGS techniques for CNV detection are plagued with a high number of false-positive calls and are challenging from a cost perspective when verifying numerous exon aberrations with orthogonal methods. Relevant gene lists continue to grow such that custom del/dup arrays out...

Using bioactivity profiling to support the progression of phenotypic hits
USING BIOACTIVITY PROFILING TO SUPPORT THE PROGRESSION OF PHENOTYPIC HITS
Bioactivity profiling has been traditionally used to assess the selectivity of new drug candidates in the context of target-based approaches, where pharmacological selectivity is a key requirement. Phenotypic screening provides hit molecules where the only initial constraint is activity in a functio...

The Neuroscience of Body Clocks (Online Symposium)
THE NEUROSCIENCE OF BODY CLOCKS (ONLINE SYMPOSIUM)
This online symposium will explore the neuroscience underpinning the daily rhythms of the brain. Specifically, the event will focus on the neurobiology of circadian rhythms, our 24-hour sleep/wake cycle. Leading researchers will discuss their work investigating the neural circuitry that wakes us up ...

Sequence Your Biopharma N-Glycans in as Little as 1 Hour
SEQUENCE YOUR BIOPHARMA N-GLYCANS IN AS LITTLE AS 1 HOUR
If you are working with N-linked carbohydrates of glycoproteins in the biopharmaceutical or biomedical fields, imagine the amount of time you can save with either semi- or fully-automated CE methods providing you information in just 60-120 minutes. Comprehensive analysis of the N-linked carbohydrate...

Automated assessment of Liver and Cardiac toxicities in lead optimisation, using biochemical and human iPS cell assays
AUTOMATED ASSESSMENT OF LIVER AND CARDIAC TOXICITIES IN LEAD OPTIMISATION, USING BIOCHEMICAL AND HUMAN IPS CELL ASSAYS
In this two-part webinar, both automation of P450 (CYP) assays and the automatization of cellular differentiation processes and compound testing using human induced pluripotent stem cells based assays was covered.  Metabolism of drugs is a key factor in compound toxicity, and automated assays w...

How to make digital work in medtech
HOW TO MAKE DIGITAL WORK IN MEDTECH
The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech.
It’s transforming how the sector reaches and engages with its stakeholders and customers, and in doing so provides vital o...

Investigating the role of microRNAs in pancreatic cancer progression
INVESTIGATING THE ROLE OF MICRORNAS IN PANCREATIC CANCER PROGRESSION
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with a 5-year survival rate of approximately 6%. Despite recent efforts in developing novel therapies, chemotherapy remains the standard of care for advanced pancreatic cancer patients. MicroRNAs (miRNAs) are short non-coding RNAs that act ...

CANCER IMMUNOTHERAPY: EXPERIMENTAL MODELS AND APPROACHES
CANCER IMMUNOTHERAPY: EXPERIMENTAL MODELS AND APPROACHES
The mammalian immune system has developed surveillance mechanisms that can detect cancerous cells. However successful tumor cells have evolved strategies to evade detection. Current therapeutic strategies focus on improving cancer cell recognition and tumor elimination. Both immunocompetent and immu...

Diagnostic and Therapeutic Patent and License Strategies
DIAGNOSTIC AND THERAPEUTIC PATENT AND LICENSE STRATEGIES
Dr. Lisa Haile presents this webinar exploring issues and strategies for diagnostic and therapeutic patents and licenses. This webinar will address questions such as: Are diagnostic tests patentable? What are the effects of the Alice ruling and the Myriad Genetics case on patents? What strategies ca...

Raman spectroscopy measurements during Bioprocessing
RAMAN SPECTROSCOPY MEASUREMENTS DURING BIOPROCESSING
Raman spectroscopy has been seen as the spectroscopic tool used in bioprocessing to monitor and control cell metabolism to optimize quality and yield of titer. This is due to Raman’s insensitivity to water and the ability to analyze samples without manipulation. However, there are certain chal...

Development and Manufacturing of Recombinant Nanoparticle Vaccines
DEVELOPMENT AND MANUFACTURING OF RECOMBINANT NANOPARTICLE VACCINES
A recombinant vaccine technology platform based on highly purified, properly-folded protein antigens in stable well-defined Nanoparticles, enabling the efficient and safe manufacture of vaccines against highly pathogenic targets. Nanoparticles are intrinsically immunogenic, producing both durable ne...

Fast and complete cyclic peptide metabolite detection and characterization by LC-MS
FAST AND COMPLETE CYCLIC PEPTIDE METABOLITE DETECTION AND CHARACTERIZATION BY LC-MS
Cyclic peptides have emerged as next-generation therapeutic agents, due to their unique structure and potential biological function. However, the study of cyclic peptide drug metabolism by LC-MS is challenging because these therapeutics typically d...

EFIRM Liquid Biopsy (eLB)
EFIRM LIQUID BIOPSY (ELB)
The advent of personalized medicine employing molecularly targeted therapies has markedly changed the treatment of cancer in the past decade. The liquid biopsy is a rapidly emerging field to address this unmet clinical need as diagnostics based on cell-free circulating tumor DNA (ctDNA) can be a sur...

Optimised genome editing of PSCs enabling efficient production of disease models
OPTIMISED GENOME EDITING OF PSCS ENABLING EFFICIENT PRODUCTION OF DISEASE MODELS
Therapeutic development for human diseases continues to face obstacles, particularly in translating targets or compounds identified by in vitro screening campaigns to valid targets or efficacious and safe compounds once tested in humans. Here we discuss strategies that leverage induced pluripotent s...

Legal Aspects in Representing Clients With Dementia
LEGAL ASPECTS IN REPRESENTING CLIENTS WITH DEMENTIA
Whenever individuals or their families are faced with a medical diagnosis of dementia, they are confronted with daunting questions--how to provide for care when the patient can no longer manage his or her own affairs, what to do to protect their rights and property, and how to cope with the day-to-d...

Freeze Drying Solutions For Your Lab
FREEZE DRYING SOLUTIONS FOR YOUR LAB
Does your work require you to freeze dry samples? Are your results inconsistent? Is your freeze dry cycle taking too long? Learn how to optimize your lyophilization process. This webinar will discuss freeze-drying techniques, as well as new accessories and advancements in laboratory freeze dryers th...

Making Polychromatic Flow Cytometry easy after Instrument Characterization and Validation
MAKING POLYCHROMATIC FLOW CYTOMETRY EASY AFTER INSTRUMENT CHARACTERIZATION AND VALIDATION
Polychromatic flow cytometry is a powerful tool in measuring and quantitating the expression of numerous antigens present on a single cell. Different instrument configurations or instruments with similar configurations can result in varied results with some populations not being easily resolved. In ...